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ABSTRACT
INTERACTIONS OF ETHANOL AND METHADONE

Vijay Aggarwal, Ph.D.
Medical College of Virginia - Virginia Commonwealth University, 1977.
Major Professor:

Dr. R. J. Bath

The effects of ethanol administration on the antinociceptive activ• ity, lethal properties and brain concentration of methadone, were inves

tigated. The effect of ethanol on the antinociceptive activity of metha
done was assessed by the hot-plate and tail-flick tests. Concentrations
of methadone in the brain were detennined by the use of 3H-methadone as
well as by gas liquid chromatographic analysis. The study showed that

moderate doses of ethanol did not alter tail-flick or hot-plate response
by themselves. However, when combined with methadone, ethanol produced

a significant increase in the antinociceptive effectiveness of methadone
as measured by both a decrease in the ED50 of methadone and by an in

creased intensity and prolonged duration of methadone antinociception.

Ethanol increased the antinociceptive activity of methadone in both naive

and methadone-tolerant mice. This increased activity was not due to

simple addition of subthreshold effects of ethanol nor was it due to an
ethanol-mediated increase in whole brain·concentrations of methadone.

is hypothesized that the increased antinooiceptive activity was the re

It

sult of an ethanol-mediated increase in central nervous system sensitiv�
ity to the antinociceptive activity of methadone.
1

Ethanol pretreatment produced significantly 1 ower brain concentra
tions of methadone compared to controls when methadone was administered

subcutaneously. When both drugs were administered orally, ethanol ad

ministration resulted in brain concentrations of methadone initially less
than control and at later times greater than control.

In both ethanol

and water-pretreated mice there was an excellent correlation between the
whole brain concentration of methadone and antinociceptive effect, but

the antinociceptive effect at any brain concentration of methadone was

greater in ethanol-pretreated mice.

Although ethanol produced signifi

cant alterations in the brain concentration of methadone, the brain con
centration of ethanol was generally not altered by methadone administra

tion.

Investigations of the excretion of methadone and its metabolites

and the half-life of methadone in the brain failed to reveal any signif

icant ethanol-induced alterations.

A dose of ethanol which increased the antinociceptive activity of

methadone did not alter the oral or subcutaneous LD50 of methadone, al
though mice that died as a result of ethanol and methadone administra
tion died at lower whole brain concentrations of methadone than those

that died as a result of methadone alone. The LD50 of ethanol was sig
nificantly decreased in mice maintained on a methadone dose of 100 mg/
kg/day.
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INTRODUCTION
A)

Methadone
Methadone exhibits a spectrum of pharmacological effects very

similar to that of morphine (28) in that both drugs produce analgesia,
respiratory depression and hypothermia. Soon after its discovery it was
known that methadone could substitute for morphine in addicts and that
similar to morphine, continued use of methadone produces tolerance and
physical addiction in man (74), although advantage of this observation was
not undertaken on a large scale until recently.
Like other narcotics, the analgesic effect of methadone is stereo
selective.

The }_-isomer is approximately 20 times as effective·an

analgesic as the i-isomer following·subcutaneous administration (146).

The affinity of }_-methadone for opiate receptors in brain homogenates is

approximately 10 times that of the .9..-isomer but only one-fourth that of
morphine (119). Although intrinsically less effective than morphine, the
analgesic activity of methadone is enhanced by its high lipid solubility
as evidenced by an oil/water distribution coefficient almost 1,000 times
that of most other narcotics (80).

This high lipid solubility accounts

for two important properties of methadone. First, as shown by bolus
injection of labeled drugs into the common carotid of the rat, the pene
tration of methadone through the blood-brain barrier is much greater than
morphine and is almost as great as the uptake of heroin (115).

In addi

tion, methadone is very effective when given orally as evidenced by the
fact that the ED50 when given orally is only 8.5 times the ED50 when
given subcutaneously (146).

2

The structures of known metabolites of methadone in humans and rats
are presented in figure 1.

The major metabolic pathway for methadone

is N-demethylation and subsequent non-enzymatic cyclization to 2-ethyl
idene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) and then further
N-demethylation to 2-ethyl-5-methyl-3,3-diphenyl-1-pyrroline (EMDP)
(124).

Additional metabolites such as methadol (I), N-desmethyl metha

dol (II), l,5-dimethyl-3,3-diphenyl-2-pyrrolidone (IV) as well as the
conjugated hydroxy derivatives of methadone (VI), EDDP and EMDP have been
isolated from human urine by various workers, most recently by Anggard
et tl· (5).

Beckett (17) also has proposed the formation of methadone

N-oxide (V), although other workers have not been able to substantiate
this finding. The only metabolites which possess antinociceptive
activity are the methadol and N-desmethylmethadol derived from Q_-metha
done. The corresponding metabolites of 1.-methadone are almost inactive
as analgesics (152).
Misra and Mule (107) have proposed that 1.-methadone but not Q_
methadone forms a methadone-derived compound which is tightly bound to
brain tissue and is responsible for the differences in activity of the
isomers and for the development of tolerance.

Although there has been

no direct evidence to refute this possibility, Sullivan et tl, (151)
reexamined the metabolism of both isomers and did not find any evidence
to support th.is concept although they were looking only at metabolites
excreted in the rat bile and not at metabolites in the brain. They
suggest that the "tightly bound" radioactivity found by Misra and Mule
is due to exchange or metabolism of their tritium label.
Although methadon.e gains access to the centra1 nervous system (CNS)

FIGURE 1
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to a greater degree than some narcotics, only a small portion of the
total dose reaches the brain.

Studies of the distribution of methadone

in man (128), rat (94) and mouse (141) all show that the plasma and
brain concentrations of methadone are very low in comparison to the
levels found in the lung, liver, spleen and kidney.

In addition to

rapid passage of met�adone from the general circulation to tissue sites,
methadone has been found to be extensively bound to human plasma pro
teins (116).

The high concentration of methadone in tissues may con

tribute to its long half-life in man by serving as a depot for the
drug.
In non-tolerant inclividuals Verebely rt .tl_. (164) found a biexpo

nential decay of plasma-methadone levels. The first phase had a half
life of 14 hours ancl the second phase had a half-life of 53 hours.

As

the patients became tolerant and the methadone dose was increased, the
plasma .half-life became mono-exponential with a half-life of 22 hours.
In their study the percentage of the daily dose recovered in 24 hour

urine and feces as methadone and EDDP was 19.2% and 3% respectively
which increased to 42% and 20% respectively after 26 days of treatment.
During the course of this study the daily dose of methadone was increased
from 15 mg/day to 80 mg/day. The predominate product in the feces was
EDDP while urine contained both methadone and EDDP. The urinary.excre
tion of EDDP increased more rapidly than the excretion of methadone
during treatment which, coupled wit� the shortened overall plasma half1 ife, was interpreted by the authors as indicating an induction of metha
done metabolism.
The qualitative metabolism of methadone in rats appears to be the

5
same as in humans (108, 151), In rats with biliary fistulas, Baselt and

Casarett (10) found that

54%

of a subcutaneous dose of methadone �ias

excreted via the bile as EDDP while only

4,.2%

and

6,0%

was excreted in

urine as EDDP and methadone, respectively, These authors found very

little methadone or EDMP in bile but did find a water-soluble metabo
lite which accounted for

30%

of the dose, They later (9} identified

this metabolite as a conjugate of hydroxy-EMDP. By examining the par

tition coefficients of methadone, EDDP and EMDP, they found that EMDP is

a somewhat unusual metabolite in that it is less polar than the parent

methadone, and thus requires hydroxylation and conjugation in order to·

be polar enough to be excreted. Since it has been shown that methadone
and its metabolites in bile are not significantly reabsorbed from the
intestine (160), the high concentration of methadone metabolites in

bile would indicate this to be a major pathway of excretion of metha
done in intact rats.
Misra et.!!]_. (108) have shown that the half-life of methadone in

rat brain after a subcutaneous dose is approximately

2,4

hours, Admin

istration of methadone 10 mg/kg/day subcutaneously for 6 weeks shortened
the half-life to 1,5 hours, This apparent demonstration of the ability

of methadone to induce its own metabolism in vivo is supported by several
studies (103, 148) where oral administration of methadone at doses in
the range of

50

mg/kg/day produced a significant increase in the rate

of methadone metabolism in vitro in the supernatant fraction of liver.
These studies also tend to support the suggested increases in methadone
metabolism seen in methadone maintenance patients,

The controlled, 1 ong-term administration of methadone. for the purpose
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of treating heroin addiction was begun by Dole and Nyswander in 1964
(44).

Their approach was to administer gradually increasing doses of

methadone until patients were receiving 80-120 mg/day. This treatment
was designed to induce a high degree of tolerance to narcotics so that
the addict would not feel the need for, nor derive any euphoric effect
from a "normal" injection of an illicit narcotic. During prolonged use
of these high doses of methadone, tolerance to almost all the narcotic
effects is dramatic, although constipation and sweating often remain a
problem.

Medical examination of patients who have been in methadone

maintenance programs for several years failed to reveal any significant
alterations in the general health of the patients during the course of
treatment (83).
The use of methadone maintenance unquestionably decreases the use
of heroin.

Even in the absence of counseling and additional programs

aimed at rehabilitation, the simple removal of the constant need for
the addict to find his next fix is a significant step in the alteration of the addict's life-style which should improve his chances to
avoid future drug use.

More recent programs l1ave placed an increased

emphasis on vocational, social and educational services in addition to
simple dispensing of methadone· to facilitate the reentry of the metha
done maintenance patient into the mainstream of society (4). Although
the substitution of methadone for heroin works well, the results of
long-term followup of patients once they leave treatment are less encour
aging.

Even the original proponents of the treatment seem fairly pessi

mistic about the long-term "cure" (45).

They cite statistics which

show that of 204 patients who left treatment, almost half had resumed

7

use of illicit opiates. The remainder had become alcoholics, addicted
to other drugs, been arrested or died. Only 22 of the 204 could be
classified as in satisfactory status.

Thus,. while methadone maintenance

provides the addict the opportunity to refrain from herion, the bene

ficial effect may last only as long as methadone maintenance is contin
ued.

Despite the poor prognosis after leaving, the benefits to the

individual and society during treatment apparently justify the contin

uation of methadone maintenance, as evidenced by the growth in the number

of people currently under treatment.

From the initial pilot program in

1964 there were an estimated 80,000 people i.n methadone maintenance
during 1975 (57).

This popularity has generated much interest in the relationship of

dose to plasma level to the incidence of symptoms during long-tenn admin
istration of methadone. It is clear from several studies that different
patients maintained on the same dose of methadone exhibit a large vari

ation in plasma methadone values at any given time (70, 164). This is

probably a reflection of the fact that even in the same patient on the

same dose there are dramatic (sometimes almost two-fold) alterations in

the plasma-methadone level from week to week, although these alterations
in plasma level are only rarely correlated with patient complaints (40).

Goldstein {58) has shown that the use of 160 mg/day vs 80 mg/day does

not generally produce a better treatment record when evaluated on the

basis of clinic attendance, use of illictt opiates, or side effects

reported. In addition, decreases of dose at the rate of 5 mg/week are
generally not detected by the patient, although doses below 50 mg/day

,are. often not satisfactory (57).

.8

These observations indicate that above a certain level (e.g. 50
"mg/day) the absolute level of methadone is not important in blockade
of heroin use. The maintenance patient becomes tolerant to the daily
dose, and gradual changes in plasma levels, whether due to intentional
dose alteration or alterations in absorption, distribution_, metabolism
or excretion of the dose, are not detected by the patient. However, as
also pointed out by Goldstein (58), rapid alterations jn dose will be
detected if they alter the amount of methadone available more rapidly
than the level of narcotic tolerance is altered.
B)

Ethanol
Ethanol passes rapidly across· all mucosal membranes and thus is

well absorbed from most routes of administration (167}.

Once absorbed,

ethanol rapidly distributes to all tissues, the rate of equilibration
with blood being largely a function of the degree of vascularization
and rate of blood flow.

Equilibration of ethanol with the brain, for

example, is very rapid as evidenced by a single pass extraction ratio
of 93% (40). Th.e equilibrium distribution of ethanol is fairly uni
form and generally follows the water content of the tissue. Jhus,
brain and liver ethanol concentrations are approximately equal and
only slightly lower than blood ethanol concentrations {77), a distribu
tion markedly different from most other drugs.
The major route of elimination of ethanol is by metabolism.

Elim

ination of ethanol by excretion generally accounts for less than 10% of
the total dose administereda The major, if not the only, enzyme respon
sible for the metabolism of ethanol

.:ill vivo

is alcohol dehydrogenase

g
(AOH) (105).

This enzyme reaches its maximum velocity at very low con

centrations of ethanol and thus the metabolism of ethanol follows zero order kinetics until blood-ethanol concentration falls to approximately
10 mg/100 ml (77).

The AOH-mediated oxidation of ethanol to acetalde

hyde results in reduction of NAO to NADH and it is the availability of
NAO which limits the rate of AOH (165).

The acetaldehyde formed is

rapidly oxidized to acetate again with the reduction of NAO to NAOH.
Since the oxidation of acetaldehyde is faster than the rate of ethanol
metabolism, acetaldehyde concentrations remain low and approximately
constant irrespective of the concentration of ethanol (123).
In addition to ADH there are two other enzyme systems which have
been proposed to play a role in the metabolism of ethanol .f.!l vitro.
These are catalase in the presence of a hydrogen peroxide generating
system (81), and the NADPH-dependent microsomal ethanol oxidizing system
(MEOS) advocated by Lieber and coworkers (88),

Although the .f.!l vivo

rate of hydrogen peroxide production is too low to permit a significant
contribution of catalase to the metabolism of ethanol in vivo, it has
been proposed that the observed microsomal metabolism of ethanol is due
to contamination by catalase (127).

Whatever the exact nature of the

microsomal metabolism of ethanol, its contribution to _the metabolism of·
ethanol iD_ vivo is probably small since pyrazole, which i:nhibits the
activity of ADH in vitro, has little effect on MEOS, and does not alter
catalase activity, is able to inhibit as much as 90% of the metabolism of
ethanol in vivo (105).
Prolonged feeding of ethanol results in a metabolic tolerance which
has been proposed to be a result of an induction of MEOS (87),

However,
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chronic ethanol feeding also increases the activity of the sodium�
potassium activated ATPase which would increase the concentration of
ADP (159).

This would stimulate mitochondrial reoxidation of NADH and

could also account for increased ethanol metabolism by way of ADH.
Despite extensive investigation, the mechanism or mechanisms by
which ethanol produces its effects on the central nervous system (CNS)
remain far from resolved.

Studies of the effect of ethanol on isolated

axons have shown that ethanol is capable of producing a slight depola
rization, decreasing the rate of rise of the action potential, and
also decreasing the size of the action potential (163). Although these
effects would be consistent with the depressant properties of ethanol,
these alterations are only observed at concentrations which would be
lethal to the intact animal.

Similarly, ethanol has been shown to in

hibit both the increase in intracellular sodium and the decrease in
intracellular potassium caused by electrical stimulation of rat brain
cortex slices (75) but again, at ethanol concentrations of 1.0 to 2,0%.
Although drastic concentrations of ethanol are required to produce an
observable change in these systems, smaller concentrations may produce
alterations in these functions which, although unobservable, could
still be important in the generation of ethanol's CNS effects .:iI!_ vivo.
In the last few years, interest has intensified in studies which
su9gest a common link between chronic ethanol and/or opiate use.

For

example, Ho et tl· (68) have shown that in mice or rats chronically
drinking ethanol, a single dose of morphine or methadone will decrease
the amount of ethanol consumed.

In addition, withdra11al of morphine

from animals addicted to morphine increases their consumption of ethanol.
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On the other hand, Blum��- (21) have shown that morphine is able to
decrease the severity of the ethanol withdrawal syndrome in mice while
concurrent naloxone treatment during the course of chronic ethanol expo
sure decreased the resultant withdrawal syndrome when ethanol was dis
continued (20).

These authors speculate that these findings may be a

reflection of the formation of tetrahydroisoquinoline alkaloids from con
densation of aldehydes and catecholamines.

It has been shown that acetal-

dehyde promotes the formation of tetrahydropapaveroline from condensation
of dopamine and its first metabolite, dihydroxyphenylacetaldehyde in rat
brain homogenates (43).

This alkaloid has also been detected --in vivo

(161) after administration of ethanol and dopa, but not after a single
dose of ethanol alone.
Another tetrahydroisoquinoline alkaloid, salsolinol, derived from
direct condensation of acetaldehyde and dopamine, has been detected in
the brain of rats treated with pyrogallol and ethanol but again not in
the brains of rats administered ethanol alone (38). The findings that
salsolinol depletes regional brain calcium (as do morphine and ethanol)
(132) and that salsolinol has some opiate activity in the guinea pig
ileum, (62) suggest that the link between these ethanol-derived alkaloids
and opiates may be a viable one.

A major criticism of this link has been the failure to detect these

alkaloids without prior pharmacological treatment.

However, since these

alkaloids are taken up by catecholamine neurons (64) they may be effec
tively concentrated and produce significant effects at very low whole

brain concentrations.

In addition, a recent report indicates that sal-

solinol is detectable in brains of mice exposed to ethanol vapour for
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five days without prior treatment with either dopa or pyrogallol (61).
As analytical methods improve it may be possible to evaluate the forma
tion of these products even after a single dose of ethanol and thereby
further investigate their role in the acute and chronic effects of ethanol
especially as they relate to opiate interactions.
C)

Ethanol and Other Drugs
The investigation of the effects of drug combinations has been of

concern for many years. As one of the most frequently used drugs, the
study of the effects of ethanol in combination with other drugs has natur
ally generated much interest, and several reviews of the field are avail
able (50, 82, 125, 169).

In addition to documentation of ethanol-drug

interactions, investigators have started to ask how these interactions
are produced.

In this,respect, the work of Rubin and Lieber and their

coworkers has been of fundamental importance in emphasizing the ability
of ethanol to inhibit the metabolism of many drugs both
vitro (133).
Although ethanol decreases the

iii.. vivo

iii.. vitro metabolism of

it is not a uniform inhibitor of all drug metabolism.

and

iii..

many drugs,

In general, etha

nol is a more potent inhibitor of the metabolism of type II drugs such as
aniline than of the metabolism of type I compounds such as pentobarbital
(133).

For example, an ethanol concentration of 12.5 mM reduced the

p-hydroxylation of aniline to 50% of control, but an ethanol concentration
of 660 mM was found necessary to produce the same degree of inhibition of
, the N-demethylation of ethylmorphine (35).

Similarly, Liu et�- (93)

found that the N-demethyl ati on of benzphetamine, another type I drug,

13

was not altered by an ethanol concentration of 100 mM. These observa
tions may be due to the fact that ethanol shows some similarities with
-type II compounds.

Addition of ethanol to microsomes produces a spectral

change similar to that produced by type II compounds (134), and also
decreases the rate of NADPH-cytochrome P450 reductase (133).

Ethanol has

also been reported to decrease the binding of aniline but not hexobar
bital (135).

However, later work has demonstrated the ability of higher

ethanol concentrations (100-200 mM) to decrease hexobarbital binding as
well (32).
In addition to its effects on drug metabolism in vitro, an acute
dose of ethanol is able to decrease the rate of elimination of a variety
of drugs in vivo.

Rubin et�. (133) showed that ethanol could decrease

the rate of decline in whole blood-pentobarbital concentration in rats
as well as in humans.

The increased half-life of pentobarbital in rats

was paralleled by an increase in the whole body half-life of pentobar
bital which would indicate the alterations observed were not due solely
to redistribution of drug. These workers also demonstrated an ethanol
mediated increase in the half-life of meprobamate in the blood of humans.
In these studies they gave an initial ethanol dose of 1 g/kg followed by
24 g/subject every two hours thereafter and thus maintained a.fairly high
ethanol concentration for the duration of. the drug hal f-1 ife measurements.

Carpenter et�. in a very complete analysis of ethanol-mepro

bamate interactions (24), found blood-meprobamate concentration in hum
ans to be unaffected by a single dose of ethanol until at least 0.75 g/kg
was· administered,

Similar studies in humans have failed to reveal an

ethanol-mediated alteration in serum concentrations of oxazepam (99),
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diazepam and thioridazine (90) and dilantin (138), perhaps since these
experiments all employed an ethanol dose of 1.0 g/kg or less.
Studies in rats where higher doses of ethanol can be employed have
shown significant alterations in drug concentration.

For example, simul

taneous intraperitoneal administration of glutethimide and 2.5 g/kg etha
nol produced an initial decline in whole brain levels of glutethimide
compared to control animals which was followed by a large increase in
concentration 4 and 8 hours after the dose (67).

It was also noted that

ethanol treatment increased the brain/plasma ratio of glutethimide and
caused an alteration in the within-brain distribution such that eleva
tions in the pons-medulla concentration of glutethimide were greater than
in the remainder of the brain.
Oral administration of ethanol 30 minutes prior to oral administra
tion of diazepam produced initially lower levels of diazepam and metabo
lites in rat blood followed by concentrations greater than controls at
later time periods (172). Ethanol also increased the whole brain concen
tration of diazepam and metabolites and increased the relative amounts
of diazepam/metabolites in brain.
Combined intraperitoneal injection of ethanol and barbiturates has
been shown to result in higher brain concentrations of pentobarbital (158)
and phenobarbital (37) although the apparent half-life of pentobarbital
in blood was not altered.

Thus some of the increase in brain and blood

barbiturate concentration may be due to increased absorption. Thomas
et al. also noted that ethanol-treated rats excreted a smaller amount of
pentobarbital metabolite (158), a finding similar to that of Coldwell et
al. (36) who noted an increased concentration of phenobarbital and
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decreased excretion of p-hydroxyphenobarbital in ethanol-treated rats.
In none of the above studies was an alteration in the brain/blood distri
, bution of barbiturate noted.
Malloy and Baesl (100) found that oral administration of ethanol
two hours before intravenous administration of zoxazolamine or warfarin
caused a significant increase in the plasma half-lives of these drugs in
the rat. These authors attributed this increase to decreased microsomal
metabolism of these drugs.
Chung and Brown (30, 31) have advanced the hypothesis that ethanol
mediated decreases in the rate of elimination of hexobarbital jl]_ vivo may
be due not only to a direct effect of ethanol but also to an indirect in
hibition of metabolism due to an ethanol-mediated increase in steroid
release.

They observed similar effects on elimination of hexobarbital

in rats which were either administered acute stress by way of hindlimb
ligature or ethanol.

Further, inhibition of the metabolism of hexobar

bital in 9000 X G supernatants after an jl]_ vivo dose of ethanol was only
found in preparations from intact rats and not in preparations from
adrenalectomized rats. These studies serve to illustrate that ethanol
mediated alterations in the brain concentration of various drugs may be
produced by the sum of many different effects.
As might be expected, combination of ethanol with other CNS depres

sants generally results in an increased toxicity which is the result of
addition of the individual effects of each drug. Accordingly, barbi
turates (173) as well as glutethimide (104) and chloral hydrate (53) are
more toxic in ethanol-treated animals than they are when administered to
control animals. A similar increase in toxicity is· observed with combi-
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nations of ethanol and tranquillizers such as chlorpromazine, promazine
and promethazine ( 48).
Combination of ethanol with drugs \�hich have some CNS stimulant
properties are less easy to predict.

For example, even though ethanol

decreases the metabolism and excretion of amphetamine, and may produce
increased tissue levels of amphetamine, there is no alteration in the
LD50 of amphetamine (76). The results of administration of various mix
tures of ethanol and chlorpheniramine show that low doses of ethanol
actually antagonize the lethal effects of chlorpheniramine (145).

These

results may be a reflection of the ability of ethanol to counteract some
of the stimulant effects of these drugs.
The combined toxicity of ethanol and opiates has been studied as
well.

Wagner and Wagner (166) found that the simultaneous subcutaneous

administration of etha·nol and methadone produced an increased toxicity

which was approximately equal to the sum of the individual toxicities.

The same conclusion was drawn by Eerola concerning the toxicity of ethanol
and morphine (47).

More recent investigations of the toxicity of a wide

range of ethanol and morphine doses by McCoy et�. (97) revealed addi
tive toxicity at high doses of ethanol but as observed with some stimu
lants, low doses of ethanol protected their mice from the lethal effects
of morphine. The authors ascribe this protection to the depressant pro
perties of ethanol counteracting some of the stimulant properties of
morphine.
None of these investigators determined the concentration of drug in
the CNS at the time of death and thus were not able to assess the impact,
if any, of ethanol mediated alterations in drug disposition on the
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observed results.
D)

Other Drugs and Methadone
Although the effects of ethanol on the disposition of methadone

have not been previously studied, the effect of other drugs on the meta
bolism and distribution of methadone has been examined.

For example,

chronic pretreatment of rats with phenobarbital has been shown to in
crease microsomal metabolism of methadone and to decrease the antino
ciceptive activity of methadone (3).

Other workers have also shown that

phenobarbital pretreatment increases the microsomal metabolism of metha
done 1I!. vitro and suggest that this increased metabolism is responsible
for the increased biliary excretion of methadone and methadone metabo
lites observed after chronic phenobarbital administration (129).

In a

similar vein, pentobarbital-pellet implantation has been shown to de
crease the antinociceptive and toxic effects of methadone while increas
ing microsomal ethylmorphine N-demethylase activity in mice (69).
In addition to the barbiturates, chronic treatment with rifampin
may have the ability to induce the metabolism of methadone.

Kreek et

al. (84) have shown that the combination of chronic rifampin treatment
with methadone maintenance results in a decrease in plasma methadone con
centration in humans when compared to periods when rifampin was not ad
ministered.

However, the consistently lower plasma concentrations of

methadone were not consistently accompanied by either shorter half-lives
of methadone in plasma or consistent increases in excretion of methadone
and metabolites, indicating that rifampin may alter methadone concen
trations by other means in addition to microsomal enzyme induction.
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Several agents have been shown capable of inhibiting methadone meta

bolism or increasing the half-life of methadone in vivo. Pretreatment
of mice with SKF-525A has been shown to increase the concentration of

methadone in plasma and several tissues when compared to animals receiv

ing methadone alone (141). The j__!!_ vitro metabolism of methadone is inhib

ited by diazepam (148), although pretreatment of mice with diazepam or ox

azepam does not alter the brain or plasma concentration .or half-life of

methadone j__!!_ vivo (142). Whether this difference is due to a species

difference or to other j__!!_·vivo effects of the benzodiazepines which mask
alterations in the metabolism of methadone in vivo is not known.

Liu and

co-workers (92, 94) have found desipramine pretreatment capable of in
creasing both the antinociceptive effect and tissue concentration of

methadone in rats.

In addition, desipramine inhibits metabolism of meth

adone J_TJ_ vitro and inhibits the biliary and urinary excretion of methadone
and its metabolites.

Thus, despite the existence of studies of the effects of ethanol

on drug disposition and of the effects of various drugs on methadone

disposition, there are no studies available on the effect of ethanol on

the disposition of methadone. The need for such a study is indicated by

the information available on the incidence of the combined use of these
two agents.
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E)

Ethanol and Methadone
Although all methadone maintenance clinics collect random urine

samples from their patients for the purpose of detecting drug use other
than methadone, these clinics generally do not request an analysis for
ethanol (163).

There are many indications however, that alcohol use and

alcoholism are significant problems in methadone maintenance patients.
Analysis in our laboratory of a random group of 170 urine samples from
methadone maintenance patients revealed that 18% had detectable levels
of ethanol (greater than 0.02% w/v).

Scott (140) reported that 25% of

the methadone maintenance patients he studied were alcoholics by the
standards of the National Council on Alcoholism, confirming a report (67)
that in another program as many as 20% of the methadone maintenance
patients were alcoholics.
Not only is the incidence of alcoholism high, but some authors
suggest methadone maintenance may increase alcoholism.

In a program

where patients were admitted to methadone treatment only if not alco
holic, it was found that 34% were alcoholics after 4 years of methadone
treatment (140). Another study found drinking to be one of the few
significantly increased complaints during the course of methadone main
tenance (118) which correlates well with the findings of another study
which indicate that 70% of the problem drinkers in a methadone main
tenance program became so after admission to treatment (98).
These reports suggest that the use of ethanol by heroin addicts
increases during treatment in the methadone maintenance program.

This

impression is confirmed by the results of Schut (139) who found that of
100 patients, 68 drank "not at all" during daily use of narcotics, but
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after 18 months of methadone treatment, only 38 still did not report
drinking at all while 20 reported drinking "more" or "much more." A
similar conclusion is drawn by Freedman (51). Both these authors note
that alcohol use seems to increase during periods of methadone dose re
duction (detoxification). There is not complete agreement about increased
use of ethanol during methadone maintenance.

One author claims a de

crease in ethanol use (55}.. However, even in this study the overall inci
dence of heavy drinking was 10%.
The motivations for ethanol use in people using methadone are no
doubt as diverse as the alcoholic drive in any population. However, the
methadone user may have several additional reasons for ethanol use.
In a series of interviews designed to determine the nature of the illi
cit or "street use" of methadone, Agar (1) found that 33% of the people
who use another drug with methadone use wine to "boost the methadone
high." The intentional concomitant use of ethanol to intensify the
methadone effect was also noted by others (26,89). Other possible rea
sons for ethanol use in methadone maintenance patients could be: (1) to
obtain a qualitatively different high since the patient is tolerant to
the effect of narcotics, (2) decrease the side effects of methadone
maintenance, or (3) as a device for access to a different social group.
Bihari (18) indicated that very often the amount of alcohol con
sumed by a methadone-maintenance alcoholic far exceeds that of a non
opiate alcoholic and that as a consequence, the development, and medical
consequences of, alcoholism in these people is much more rapid and
severe. The incidence of alcohol use and alcoholism in methadone main
tenance patients has motivated several centers (27 ,89,126) to use
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disulfiram in combination with methadone to treat their patients who are
addicted to both ethanol and methadone.
An additional indication of the incidence of combined ethanol and
methadone use comes from a report of drug findings in victims of non
drug-induced violent deaths in New York City and Detroit, Michigan (13).
This study showed that of those homicide victims who were using morphine
at the time of death, 20% were also using ethanol while of those who had
been using methadone, 40% were also using ethanol. A final indication
of the magnitude of the combined use of ethanol and methadone comes
from reports of the findings in cases of methadone overdose.

The fre

quency with which ethanol is found in published surveys of methadone
overdoses varies.

One study found that in sixteen cases of methadone

overdose, thirteen had also ingested ethanol (26). This high incidence
of ethanol in methadone deaths is not found in other studies (14, 101,
128) although ethanol is frequently associated wi1h methadone deaths in
these reports. A more reliable index of the involvement of ethanol in
methadone deaths is obtained from the National Registry of Human Toxi
cology which is compiled from voluntarily submitted toxicology reports
from the entire United States (lll). The results in the Registry for
1973-1976 show that 20% of the reports of methadone-induced death also

involved ethanol.

The degree of narcotic tolerance in the victims of methadone over
dose is often hard to determine.

Some are known to be tolerant, as they

were enrolled in a methadone maintenance program. Others are thought
to be non-tolerant by virtue of their recent confinement in a hospital
or jail.

In the remainder of the cases the victim may have been an
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occasional or chronic user of illicit methadone.
One would expect the methadone maintenance patient to be less sus
ceptible to methadone overdose, but there exists one report (130) that
patients maintained for long periods of time on high doses of methadone
have a much higher death rate �1hen they are al so addicted to ethanol.
Reporting on the results of analyses of methadone overdoses in New
York City, Bastos (12) noted that the brain concentration of methadone
in deaths due to ethanol and methadone tended to be lower than in cases
of death attributed to methadone alone. However, the variability in the
levels in both groups precluded a definite statement about the role of
ethanol in these deaths.

Much of the variability was probably due to

the various degrees of narcotic tolerance in the cases examined, which
cannot be controlled or even ascertained in human postmortem studies.
F)

Present Study
This study was motivated by the information summarized above which

indicates that there is a significant human exposure to combinations of
ethanol and methadone.

It is the purpose of this study to evaluate the

nature and magnitude of some of the interactions of these two agents
when administered in a controlled situation to laboratory animals.
interactions to be studied are summarized as follows:
1)

The

Effect of ethanol on the pharmacological activity of methadone

Since methadone is both used and abused for its effects on the cen
tral nervous system, the most meaningful effect to monitor would be a
CNS effect.

As one of the most prominent and well studied· CNS effects

of methadone is its antinociceptive activity, this was the effect
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investigated.

The activity of many narcotic drugs in the tail-flick

and hot-plate tests is well correlated with their clinical effective

ness in man (6) and for this reason they are two of the most widely
used tests of antinociception.

Therefore, the activity of methadone in

the tail-flick and hot-plate tests was used as a measure of its pharmacological activity in this study.
2)

Effect of ethanol on the magnitude and time course of brain
methadone concentration

As summarized in the introduction, ethanol has the potential for
producing significant alterations in the amount of systemically administered drug which reaches the CNS.

In view of the possibility of ethanol

mediated alterations in the absorption, distribution, metabolism or
excretion of methadone, the concentration of methadone in the brain was
determined simultaneously with antinociceptive activity. To reliably
quantitate methadone in individual mouse brains, 3H-methadone was used
in most of these experiments.
3)

Toxicity of ethanol and methadone combinations

The antinociceptive and lethal properties of methadone are pro
bably produced by effects on different systems and therefore, alterations in antinociception may not necessarily imply alterations.in lethal
effects. Thus, this study also investigated the effect of ethanol pre

treatment on the toxicity of methadone as well as the effect of chronic

methadone administration on the toxicity of ethanol.
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MATERIALS AND METHODS
A)

Materials
1) Drugs
The 1-3H-1-methadone HBr used in this study was purchased from

New England Nuclear (NEN). The initial specific activity was 110 mCi/

mmole. This was diluted with unlabled i,.l_-methadone HCl except where

noted otherwise. The unlabled methadone was obtained from Ma11inckrodt.

Unlabled .l_-methadone was a gift from Eli Lilly as were authentic samples

of the two major metabolites of methadone, EDDP and EMDP. Naloxone HCl
was a gift from Endo Laboratories, and SKF-525A was a gift from Smith

Kline and French. Propoxyphene was purchased from Eli Lilly, morphine

sulphate was purchased from Mallinckrodt, and meperidine HCl was purchased
from Winthrop Laboratories. All ethanol solutions used in this study

were prepared fresh from absolute ethyl alcohol U.S.P. purchased from
U.S. Industrial Chemicals.
2) Chemicals

Omnifluor, Aquasol-2 and the 3H-toluene internal standard were pur
chased from New England Nuclear.

Omnifluor (4 g/liter) was dissolved 1n

Scintill AR toluene purchased from Mallinckrodt. All other chemicals used

were of analytical reagent grade.
3) Animals

The mice used in these studies were male Swiss (ICR) mice weighing
between 19 and 30 g • .The rats emp.loyed were male Sprague Dawley weigh
ing between 250 and 325 g.

Animals were maintained on Purina Laboratory
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Chow for rats and mice and tap water ad libitum in an animal room with
a 12-hour light-dark cycle. Animals were purchased from Flow Research
Animals, and were allowed to acclimatize for at least two days prior to
experiment.
B)

Methods
--1)

Dosing of Animals

Unless otherwise noted, a 11 animals were deprived cif food but not
water, and placed in wire bottom cages at midnight the night before the
experiment. All experiments were conducted between 4:00 and 8:00 pm the
next day during which time the animals did not have access to either
food or water.

The start of the normal dark cycle was at 7:30 pm.

All drugs for subcutaneous injection were dissolved in 0.9% NaCl at
a solvent volume of 10 ml/kg. All drug doses are expressed as the free
base.

Methadone administered by the oral route was dissolved in deion-

ized water.

Ethanol was administered to rats as a 24% (w/v) solution

in deionized water.

Low-power microscope examination revealed that this

concentration of ethanol produced reddening and pinpoint hemorrhaging of
the gastric mucosa.

For this reason all subsequent ethanol doses were

administered as a 15% (w/v) solution. At this concentration there was
no observable damage to the mucosa.

Control animals received an equal

volume of deionized water.
Since the gross behavior of the animals was still affected by a 2.5
g/kg dose of ethanol 30 minutes after administration, but the animals
appeared normal at 60 minutes, most of the studies of the antinociceptive
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effects of ethanol and methadone combinations were done at 60 minutes
or more after the ethanol dose.
Radiolabeled methadone was diluted with unlabeled methadone to pro
duce a specific activity such that animals injected subcutaneously re
ceived 5 to 10 µCi/kg (most frequently at a specific activity of 5 µCi/
mg) and animals dosed orally received 40 µCi/kg.

Subcutaneous injec

tions were made under the skin between the shoulder blades.
Drug administrations were spaced to allow sufficient time to sacri
fice and obtain samples from each mouse immediately after testing and
still maintain the same time interval between drug injections and testing
for all mice.

Unless otherwise noted, mice were dosed and tested only

once. Animals were killed by cervical dislocation. Blood was withdrawn
from the heart with a 25-gauge needle and allowed to clot in a capped
test tube. Clotted blood was centrifuged and the serum was refrigerated.
In cases where whole blood was analyzed, it was collected over potassium
oxalate and sodium fluoride. The brain was rapidly removed, blotted
free of surface blood, wrapped in aluminum foil, and placed in a beaker
in an ice bath.
ice.

Liver and lung samples were removed and placed on dry

All tissue samples were stored frozen until analysis.
2)

Analysis of Injection Solutions

All 3H-methadone solutions were stored at 4 °C.

Any methadone solu

tion more than six months old was checked for concentration and radio
chemical purity before use. Concentration was checked by dilution with
0.5 HCl and measurement of UV absorption at 259 nm.

Radiochemical

purity was determined by extraction of an alkaline aliquot with 50 µl of
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ethylene dichloride/isopropanol (S0/20,v/v) and thin layer chromato
graphic analysis (TLC) in the solvent system described below.

The TLC

plate was scribed prior to application of the sample to provide channels
approximately 1 cm wide. After development, the zone corresponding to
methadone was scraped into a vial and the remainder of the channel was
scraped into a second vial. Isopropanol (0.5 ml) and Omnifluor in tolu
ene (10 ml) were added and the amount of radioactivity was determined.
In addition, aliquots of the injection solution were used to prepare
standards for the analysis of samples. Aliquots of the extracted aque
ous layers·were counted to monitor exchange of tritium. At no time in
the course of the study was any degradation of methadone or exchange of
label observed in the injection solutions.
3)

Measurement of Antinociception

The primary technique for the measurement of antinociception was the
modified (11) tail-flick test of D'Amour and Smith (42).

In this test

the animal's tail was placed on a notch above a photocell so as to block
the photocell. A photographic lamp mounted above the photocell was fo
cused on the tail approximately 3 cm from the end. Activation of the
lamp also started a timer placed in series. When the animal �erceived
the heat from the lamp and moved his tail, light from the lamp hit the

photocell and stopped the timer. A rheostat was used to adjust the

intensity of the lamp so that unclosed animals flicked their tails be
tween two and four seconds after activation of the lamp.
A control or baseline latency was obtained for each mouse before
dosing. At the appropriate time after drug administration , the latency
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of the tail-flick was again determined.

If animals allowed their tail

to remain under the lamp for more than ten seconds, the heat produced
marked tissue damage.

For this reason a cutoff of ten seconds was em-

ployed. Antinociceptive effects were calculated as percent of the maxi
mum possible effect (%MPE) according to this formula:
Test Latency - Baseline Latency
X 100.
%MPE �
10 - Baseline Latency
In addition, when animals responded with a test latency less than ten
seconds, their tails were replaced over the photocell with the lamp off
to confirm that they would not move their tails within ten seconds in
the absence of a painful stimulus.

This was done to decrease the con

tribution of possible random movement to the calculated antinociceptive
response.

In fact, it was found that unless the animals were held in a

very awkward position they very rarely displayed any random tail movements.

In the cases where this was found, the animal was replaced in the

cage for one to two minutes, replaced on the tail-flick apparatus with
the light off for ten seconds, and then tested.
The second measure of antinociception was the hot-plate test of
Eddy and Leimbach (46). The mouse was placed in a clear plastic cylinder
approximately 4" x 12" which was on a brass plate maintained at 57 ° c by
a recirculating water bath.

The time required for the mouse to react to

the heat by licking its front paws or lifting one of his rear paws was

measured with a stopwatch. A control reading was taken before drug ad
ministration.

The maximum time allowed was twenty seconds. The antino

ciceptive effect (%MPE) was calculated according to the following formula:
Latency - Baseline Latency
'
-_ Test 20
X lOO.
%MPE
- Baseline Latency
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Antagonism of the antinociceptive effect of methadone, or ethanol
and methadone, by naloxone was determined by administration of various
doses of naloxone to animals pretreated with ethanol and methadone in
doses sufficient to produce approximately 80% MPE. Percent antagonism
was calculated as follows:
%antagonism
4)

=

%MPE with naloxone
1 - %MPE without naloxone X 100.

Determination of Methadone Concentrations
a)

Analysis of 3H-methadone in brain

Whole brains were homogenized in 2 ml 0.5 N HCl with a glass and
teflon tissue grinder (A.H. Thomas). The homogenizer was washed with
2 x 2 ml 0.5 N HCl. The combined homogenate and washings were spiked
with 500 µg of unlabeled methadone and 25 µg of both EDDP and EMDP.
The extraction scheme, adapted from the method of Misra et�- (108),
is presented in figure 2. Each brain was homogenized and extracted
separately. The pH 9.6 NH4Cl/NH40H buffer was prepared by adjusting a
saturated solution of NH4Cl to pH 9.6 with 15 M NH40H.
Ten ml of the solvent extract from each brain or brain standard

was evaporated in an individual vial. The residue in the vials was
dissolved in 0.5 ml of isopropanol and 10 ml of Omnifluor in toluene

was added. The remaining solvent extract from all brains which came from

the same treatment group of mice·was pooled in an evaporation cup and
evaporated at room temperature under a slow air stream. The residue

was dissolved in 3.0 ml of 0.3 N HCl and transferred to a tapered centri
fuge tube. The evaporation cup was then washed with an additional 1 ml
of 0.3 N HCl.

The combined acid washings were adjusted to pH 9.6 with
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FIGURE 2
PROCEDURE FOR THE DETERMINATION OF RADIOLABELED
METHADONE IN BRAIN

homogenized brain in 6 ml 0.5 N HCl
added unlabeled methadone, EDDP and EMDP
neutralized with 12 N NaOH
adjusted pH to 9.6 with NH4Cl/NH40H
buffer
extracted with 20 ml ethylene di
chloride/isopropanol (80/20, v/v)

discarded
aqueous

solvent
washed with HCo3-;co3=
bu�fer (pH= 9.8)
discarded
aqueous

solvent
j,

evaporated 10 ml in
vial and counted

evaoorated remainder
TLC.with methanol/benzene/n-butanol/
H2D/NH40H (60/10/15/10/2-;- v/v)

��-----,����___,I
J;

corrected total DPM for
% as methadone

.
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the NH4Cl/NH40H buffer and then vortexed with 100 µl of ethylene dichlor
ide/isopropanol (80/20,v/v). The organic solution was applied to a

Silica Gel G (250 microns) plate which had been previously scribed into
1 cm channels,and developed in MeOH/benzene/rr_-butanol/H20/NH40H (60/10/
15/10/2, v/v) adapted from Beckett et�- (16). The zone corresponding
to methadone was scraped into one vial and the remainder of the channel
was placed in another vial.
described above.

Isopropanol and Omnifluor were added as

Radioactivity in all samples was determined in a Beck

man LS 300 scintillation counter and corrected for quenching by the
external stindard method. The accuracy of the quench curve was checked
by also using 3H-toluene as an internal standard in several samples
from each batch.

The results of both methods were in good agreement.

The apparent methadone in each brain was calculated by comparison
of the total DPM in the 10 ml solvent aliquot from samples to the number
of DPM in the 10 ml of solvent from blank mouse brain standards that had
been spiked with known amounts of 3H-methadone from the injection solu
tion. It was found that methadone was extracted from human-brain homogenates to the same extent as from mouse-brain homogenates an.ct thus
only one standard per batch was prepared from mouse brain, the remaining
standards were prepared from human-brain homogenates. At least two
standards were run with each ten samples.

Brain methadone was calcu-

lated by the following formula in which the apparent brain methadone was
corrected for the percent of total 3H which migrated with methadone on
TLC:
Apparent methadone (% as methadone) -_ ng methadone/gram of brain.
Brain Weight

For example:

"300 ng" (0.85)/0.45 g

=

567 ng/g.
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The coefficient of variation for thirty-one standards extracted
within a seven-week period was 7%. The recovery of added methadone from
both human and mouse-brain standards was consistently greater than 9 5%.
TLC zones were visualized with iodoplatinate spray (33). Some in
creased sensitivity was observed when the spot corresponding to EMDP
was sprayed with Dragendorff spray (33) instead of iodoplatinate. The
Rf of EDDP, methadone and EMDP were 0.21, 0.50 and 0.75 respectively.
The recovery of 3H-methadone spotted on the TLC plate was only ap
proximately 75% for both extracted samples and standards as well as an
ethanol solution of methadone applied directly to the plate.

The losses

were assumed to be due to incomplete removal of the drug from the silica
gel particles. To see if the extraction procedure or the loss of 3H
during TLC would affect the determination of brain methadone an experi

ment was carried out with pooled urine from animals that had received 3H
methadone. The pooled urine was split into two portions.

One was ana

lyzed by gas liquid chromatography (GLC), the other was added to two
blank mouse-brain homogenates and carried through the above procedures.
The GLC analysis revealed a 1/0.29/0.07 ratio (based on triplicate in
jections) between methadone/EDDP/EMDP while the average of DPM in the
corresponding TLC zones was 1/0.32/0.03. Thus, even though there is
some apparent loss of 3H on the TLC plate, the relative amount of metha
done to its metabolites is not altered and therefore the correction of
apparent brain methadone to actual brain methadone should not be altered.
b)

GLC analysis of methadone in brain

In addition to the analysis of brain methadone by the use of
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3H-methadone, it was necessary to develop a GLC procedure for brain
methadone determinations for two reasons.

First, during the course of

these experiments, it was found that the specific activity of methadone
in the brain was altered when 3H-methadone was administered by the oral
route. A more complete discussion of this problem is presented in appen
dix I.

In addition, experiments were conducted in mice maintained on

unlabeled methadone where use of radiolabeled drug would not be possible.
The GLC method employed was a modification of a procedure previously
published from this laboratory (2).
Although not affected by alterations in specific activity, the GLC
method was less sensitive than the assay based upon the 3H-label, and
therefore brains had to be pooled in groups of at least two. The brains
were homogenized in the same manner as in the 3H-label assay but were not
spiked with additional methadone or metabolites.

Fifty micrograms of the

internal standard SKF 525A (beta-diethylaminoethyldiphenylpropylacetate
HCl) was added to the brain homogenate prior to pH adjustment. This
compound has been used by others (73) as an internal standard for metha
done analysis due to its structural similarity to methadone.

The extrac

tion scheme is presented in figure 3.
The final extract vias analyzed on a Bendix 3300 gas chromatograph
with flame ionization detectors.

Each sample was injected on both a 3%

OV-101 and a 3% OV-17 column to minimize the effect of any contaminants
which would coelute with either methadone or the internal standard on
one column or the other. The peak heights and areas as well retention

times and methadone/SKF-525A ratios were determined by a Hewlett Packard
2100 computer-based data reduction system. The amount of methadone in
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FIGURE 3
PROCEDURE FOR THE DETERMINATION OF METHADONE IN BRAIN
BY GAS LIQUID CHROMATOGRAPHY

homogenized brain in 6 ml 0.5 N HCl
neutralized with 12N NaOH
adjusted pH to 9.6 with NH4Cl/NH4DH
buffer
added internal standard (SKF-525A)
extracted with 20 ml butyl chlor
ide/isopropanol (95/5, v/v)

discarded
aqueous

solvent
extracted with
6 ml 1 N HzSD 4
discarded
solvent

acid
neutralized with NaOH
adjusted pH to 9.6 with �H4Cl/NH4DH
buffer
extracted with 100 µl ethylene di
chloride/isopropanol (80/20, v/v)
GLC

3% OV-101 @205° c
3% ·ov-17 @19o0 c
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each sample was calculated by comparison of peak height ratios with
coextracted brain standards spiked with known aliquots of the injection
solution.

At least one standard was run for every four samples.

The

results from both columns were in good agreement and were averaged to
gether for each sample.
The overall recovery of methadone was 85%. The major methadone
metabolites were poorly back extracted by H2so4 but any metabolites in
the final extract did not interfere with the methadone peak under the
chromatographic conditions employed. Based on 5 standards, the within
run coefficient of variation was 6% at a level of 1 µg. The minimum
amount that could be reliably quantitated was 100 ng.
In contrast to the extraction of methadone, the recovery of the
internal standard was not the same from mouse and human-brain homoge
nates.

The internal standard recovery from human-brain homogenates was

almost exactly twice the recovery from mouse brains and thus comparison
of mouse-brain samples with human-brain standards would give an apparent
brain concentration of methadone approximately twice as high as it should
be (see appendix I).

For this reason, in addition to standards prepared

from human-brain homogenates, at least one standard prepared in blank
mouse brains was run with each batch of samples.
In addition, two analyses of pooled brain samples analyzed by this
GLC method were also analyzed by a gas chromatograph/mass spectrometer
(GC/MS).

This confirmation was performed on an electron impact, mag

netic sector mass spectrometer (Du Pont 49GB) set to monitor m/e 72 which
is the base peak of methadone and a minor peak in SKF 525A.

The GC/MS

results were in very good agreement with GLC results, the average
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difference between the t110 being 7%. The GC/MS ,ias also used to detect
any residual brain methadone at twenty-four hours after the last mainte
nance dose in methadone-tolerant mice. In the single ion detection
mode the instrument was capable of detecting 5-10 ng of methadone.
c)

Determination of methadone in serum, liver and lung

Serum was diluted with water. Approximately 0.4 g of liver or lung
were homogenized in 0.5 N HCl.

These samples were processed by the pro-

cedure described for brain. Liver and lung samples were removed from the
freezer and homogenized immediately to minimize any alterations of the
relative amounts of methadone and metabolites due to metabolism --in vitro.
d)

Determination of liver methadone and metabolites

The determination of the relative amounts of methadone and its metabolites in liver was accomplished by preparing and extracting samples
as described above. However, instead of scraping all the non-methadone
area of the TLC channel into one vial, zones corresponding to methadone,
EDOP and EMDP were scraped into separate vials.
channel was then placed in a separate vial.

The remainder of the

In addition, a known ali

quot of the extracted aqueous phase was also counted. The amount of 3H
present as methadone, EDDP or EMDP was calculated by multiplying the to
tal extractable 3H by the percentage of total radioactivity on the TLC
plate which migrated �iith each metabolite. The total radioactivity in
the organic solvent and extracted aqueous layers were summed. The ratio
of total radioactivity to the radioactivity present as methadone or each
metabolite or the radioactivity remaining in the aqueous phase was then
determined.
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Analysis of the final organic solvent extract from liver was also
performed using iTLC sheets (type SA) purchased from Gelman. Thes.e
"fiberglass sheets impregnated with silica gel were deve1 oped in either
benzene/ethyl acetate/methanol/NH4 0H (80/20/1.2/0.1, v/v) or !_-amyl alco
hol/n._-butyl ether/water (14/17/1, v/v) according to the procedure of
Misra et�- (109). After development, the strips were cut into 10-mm
sections, placed in vials with 1 ml of isopropanol and then counted as
described above.
e)

Methadone and metabolites in bile and urine

Bile and urine samples from each treatment group were pooled, di
luted with the NH4Cl/NH40H buffer, spiked with 30 pg of methadone, EDDP
and EMDP, and vortexed with 200 µl of EDC/isopropanol (80/20). The or
ganic solution was applied to a TLC plate and developed as described
above.

The samples were not hydrolyzed but simple solvent extraction

still removed 80% of the radioactivity from the urine layer 60 minutes
after methadone administration.
5)

Determination of Ethanol Concentrations
a)

Sample preparation

Serum was analyzed without further preparation.

Brain samples

were removed from the freezer one at a time, weighed, and immediately
homogenized in 2 ml of cold deionized water. The homogenate was trans
ferred to a 5 ml volumetric flask. The homogenizer was washed with
another 2 ml of cold water which was combined with the homogenate.

The

combined homogenate and wash was diluted to a volume of 5 ml with cold
water. The flask was sealed and the contents thoroughly mixed.

Brain
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samples were analyzed within 12 hours of the experiment as longer periods
of storage tended to allow some loss of ethanol even when frozen.
Samples of stomach contents were obtained by ligation of the esopha
gus and duodenum followed by removal of the stomach from the mouse.

The

stomach was opened and the contents washed into a 25-ml volumetric flask
with approximately 20 ml of cold deionized water.

The level was brought

to the mark with cold water, the flask stoppered, and the contents thor
oughly mixed.
b)

Analysis

Ethanol samples were analyzed by an automated head space analysis
using a Perkin Elmer gas chromatograph (Multifract F-40).

A known ali

quot of the sample (500 ul) was- combined- in a 20 ml vial with 4.5 ml of
an aqueous solution of �-propanol which serves _as an internal standard.
The vial was sealed and incubated at 58° c for at least 20 minutes. An
aliquot of the head space was automatically injected on a Carbopack C
column at 110° c. The ratio of the ethanol peak.height to the .!!_-propanol
peak height was determined by computer and the concentration of ethanol
in the sample calculated by comparison to aqueous standards. The total
amount of ethanol in the brain sample thus calculated was divided by
the initial brain weight to yield the concentration of ethanol in the
brain.

For example, if 381 mg of brain was homogenized in 5 ml of water

and this solution was found to contain a total of 0.602 mg of ethanol,
then the brain contained 1.58 mg/g or 158 mg/lOOg.

The concentra-

tion of ethanol in the aqueous standards was determined by a modified Cavett titration (114). The validity of using aqueous standards
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in the analysis of brain samples was verified by adding known amounts
of ethanol to blank mouse brains and preparing and analyzing them as
described.

The coefficient of variation for the ethanol analysis is

less than 2% based on analysis of thirty aliquots of a blood sample con
taining 0.10% ethanol (w/v).
6)

Locomotor Activity

The locomotor activity cages used consisted of a clear plastic
shoebox cage with a photocell at one end and a white light focu�ed on
it from the other end. The cage was covered by a wire screen.

There

were six such cages housed in a metal cabinet with a fan to circulate
air and serve as a constant "white noise" background. The photocells
were connected to an analogue counter assembly (Lehigh Valley Elec
tronics) so that the number of times the mouse interrupted the light
beam could be quantitated. Two mice were placed in each cage and the
doors to the cabinet were closed. After 10 minutes, the counter was
activated and the number of counts during the next 30 minutes was re
corded.
7)

Statistics

All ED50 1 s, 1050 1 s and Ec50 1 s and their 95% confidence intervals
were calculated and tested for significant potency and slope ratios by
the method of Litchfield and Wilcoxon (91).

All other data with excep

tion of binomial data such as %MPE was tested by the tv10-tai 1 ed t test
(150).

Binomial data (%MPE) were evaluated for significant differences

by the Mann-Whitney U test (39).

The only exception was in the evalua

tion of the effect of ethanol alone on the tail-flick and hot-plate.
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In this case the absolute latencies before and after ethanol were tested
for sig·nificant (P (.05) differences by the.!. test. This is valid since
absolute latency is a continuous, random variable as long as no animal
reaches the ten second cutoff.
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RESULTS
A)

Antinociceptive Activity of Ethanol
The antinociceptive effect of ethanol 60 minutes after admini

stration to male Sprague Dawley rats is presented in table 1.
Increasing oral doses of ethanol produced increasing whole brain
ethanol levels, however significant effects on tail-flick latency
were not observed until a dose of 4.5 g/kg was employed.
The antinociceptive effect of various doses of ethanol in ICR
mice is presented in table I'.'.. The serum and whole brain concentrations
of ethanol follow the kinetics typical of a substance whose metabolism
is described by zero order kinetics. After a dose of 2.5 g/kg brain
ethanol levels fell at a rate of 48 mg/100 g/hour.

No significant

alteration of tail-flick latency was observed from 30 to 150 minutes
following an ethanol dose of 2.5 g/kg.
Following an oral dose of 2.S g/kg of ethanol mice appeared to have
decreased locomotor and exploratory activity as well as reduced skeletal
muscle coordination.

These effects were maximal 30 minutes after the dose.

At 60 minutes after administration, ethanol-pretreated mice ex.hibited
the same behavior and muscle coordination as control mice.
Although the end point in the hot-plate test requires a more
coordinated motor response than the tail-flick, mice pretreated with
2.5 g/kg of ethanol showed no increase in hot-plate latency at 60 rninut�s.
Since an oral dose of 2.5 g/kg of ethanol did not elicit any activity
in either the hot-plate or tail-flick tests it was the dose of ethanol
used in most of the interaction studies.
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TABLE 1
TAIL-FLICK ACTIVITY OF ETHANOL IN RATS

Dose

%MPE

(g/kg, p.o.) Tail Flick

Whole Blood Ethanol

Brain Ethanol

mg/100 ml
+ SEM

mg/100 g
+ SEM

1. 5

4.8

151

+

15

2.5

3.0

169

+

39

3.0

5.0

266

+

27

4.5

10.8*

273

+

45

161

+

38

Animals were dosed with ethanol (24% w/v) p.a. and tested 60
minutes later. There were four rats/dose.
* significantly different from zero at P <.05
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TABLE 2
TAIL-FLICK ACTIVITY OF ETHANOL IN MICE

Dose
g/kg

Time After Dose
Serum Ethanol
. mg/100 ml + SEM
(Minutes)

2.5

30
45
60
90
120
150

252
222
198
167
140

4.0

60
90
120
150

413 + 67
341 + 41
311 + 33
285 + 36

6.0

60

675

Brain Ethanol
mg/100 g ±_ SEM

56
+ 40
+ 21
+ 29
+ 19
+

+

51

215
205
193
167
148
123

+

+
+
+
+
+

9
15
7a
4
8
10

319 + 21
261 + 14
223

+

16

500

+

45

%MPE
Tail-Flick
5.2
-1.0
2.ob
1.0
0.1
3.0
13

10
5
0.5
85*

Ethanol was administered p.o. as a 15% w/v solution. Mice were
sacrificed immediately after testing. There were at least six mice/group.
a Combination of this dose of ethanol with simultaneous administration
of methadone 4 mg/kg s.c. resulted in a brain-ethanol concentration
of 197 ±_ 18 mg/lOOg.
b These mice also displayed an antinociceptive effect of -5% MPE in the
hot-plate test.
* Significantly different from zero at P <.05.

As shown in table 2, ethanol at a dose of 4.0 g/kg did produce
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some elevation of tail-flick latency. In addition, at this dose the
effects of ethanol on muscle coordination and locomotor activity were
more pronounced and long lasting. When tested on the hot-plate, the
mice appeared to perceive the heat but were unable to coordinate the
normal response.

At a dose of 6.0 g/kg mice were extremely sedated

and exhibited a very marked elevation of tail-flick latency as well
as a total lack of spontaneous movement.
B)

Effect of Ethanol on Methadone Antinociception
As shown in figure 4, a 2.b g/kg dose of ethanol, which is not

active in the hot-plate test alone, when combined with methadone produces
a significant difference in the antinociceptive effect of methadone.
The test was done 60 minutes after ethanol at which time the mice had
recovered from the effect of ethanol on skeletal muscle coordination and
displayed no change of latency due to ethanol alone. The rn50 of metha
done is decreased from 3.2 mg/kg in control mice to l.6 mg/kg when com
bined with ethanol. There is no significant difference in the slopes of
the dose response curves but the ED50 1 s are significantly different at
the 95% confidence level by the method of Litchfield and Wilc�xon (91).
The combination of ethanol and methadone was also more active

than methadone alone in the tail-flick test as shown in figure 5. There
was no alteration of the tail-flick response by an ethanol dose of 2.5
g/kg. Yet, when combined with methadone this dose of ethanol decreased
the rn50 of methadone in the tail-flick test from 2.0 mg/kg to 0.8 mg/kg.
Furthermore, when pretreated with 4.0 g/kg ethanol, mice displayed a
methadone EDso of only 0.2 mg/kg.

The slopes of the dose response curves
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FIGURE 4.
THE EFFECT OF ETHANOL Oil THE HOT-PLATE ACTIVITY
OF METHADONE IN ICR MICE
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Water or Ethanol (2. 5 g/kg, p.o.) was administered 45 minutes
prior to methadone. Mice were tested 15 minutes post methadone.
N = 6/group.

FIGURE 5

46

THE EFFECT OF ETHANOL PRETREATMENT ON THE TAIL-FLICK
ACTIVITY OF METHADONE
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with 2.5 g/kg
with 4.0 g/kg
.1

.2
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so 50

(95% C.I.)

2.0 mg/kg (1.4-2.8)
0.8 mg/kg (0.5-1.3)
0.2 mg/kg (0.1-0.5)
2.0

3.0

4.0

Dose of Methadone (mg/kg s.c.)

Ethanol (2.5 or 4.0 g/kg, p.o.) or water was administered 45 minutes
prior to methadone and mice were tested 15 minutes later.
N = at least six mice/group.
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were similar but the alterations of methadone potency were significantly
different at the 95% confidence level by the method of Litchfield and
Wilcoxon (91). Thus, these data indicate that ethanol produces a
dose-related increase in methadone antinociception as measured in
both the hot-plate and tail-flick tests.
As shown in figure 6, a similar result is found in Sprague Dawley
rats.

Pretreatment with a dose of ethanol not active in the tail-

flick test (2.5 g/kg, see table I) produced a significant potentiation
of methadone antinociception as evidenced by a decline in the ED50 of
methadone from 4.3 mg/kg to 2.2 mg/kg, with no change in slope.
C)

Effect of Ethanol on Methadone Distribution
1) Methadone Concentrations in Brain and Serum
To examine the possibility that the increased antinociceptioi1 was

due to an increased c�ncentration of methadone in the brain, the con

centration of 3H-methaJone in the brain and serum of the mice used to

construct the preceding dose-response curves was examined. The results
of these determinations are presented in table 3. It can be seen that
at each dose examined, the mice which received ethanol had a lower con
centration of methadone in the brain but a greater antinociceptive
response compared to the �later-pretreated controls.

With the exception

of the combination of water and 4.0 mg/kg methadone, the brain to serum
methadone concentration ratio was approximately 1.0 and vrns not altered
by ethanol pretreatment.
As can be seen in the last column of this table the brain-methadone
concentration in ethanol-pretreated mice was decreased by approximately
20% compared to the water controls. However, ethanol potentiated
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FIGURE 6

THE EFFECT OF ETHANOL ON THE TAIL-FLICK ACTIVITY OF
METHADONE IN SPRAGUE DAWLEY RATS
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Control ED50 = 4.3 (3.1-6.0), with Ethanol Eo50 = 2.2 (1.5-3.0)
Ethanol (2.5 g/kg, p.o.) or water was administered
45 minutes prior to methadone. Animals were tested
15 minutes post methadone. N = 6 animals/group.

TABLE 3

EFFECT OF ETHANOL ON BRAIN AND SERUM METHADONE CONCENTRATION
Dose of Methadone
mg/kg (s.c.)

0.5
1.0

2.0

3.0

4.0

% MPE #
32

62

I 81

I 92

I 100

Ethanol Pretreatment
Methadone Level
ng/g _:!:_ SEM
Brain
Serum

57_:!:_8

--

284+27

38

156+15

388+36 *

493+31

642+55

*

% MPE #

63+12

139_:!:_8

309+27

Water Pretreatment

651+103

Methadone Level
ng/g _:!:_ SEM
Brain
Serum

Ratio of
Brain Levels

I

0.81

70+13

83+17

334+18

357_:!:_30 I

25

159+8

64

508+31

80

I

857+65

151_:!:_12 I

0.87

510+83

0.76

550+89

I

@

0.93

0.75

Ethanol (2.5 g/kg, p.o.) or water was administered 45 minutes prior to Methadone. Mice were
sacrificed 15 minutes later. Methadone levels were determined by liquid scintillation.
N � at least 6 mice/group. * significantly different from control at P (.05
@ Ratio of br;in methadone concentration in ethanol pretreated mice/water pretreated mice
# analgesic effect in the tail flick test.

_,,,

CD
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methadone to such an extent that even in the face of this slight
decrease in brain methadone, the dose-response curve for methadone was
still shifted to the left (figure 5).

The effect of 4.0 g/kg ethanol on brain methadone was also

examined. A dose of 0.5 or 1.0 mg/kg methadone combined with 4.0 g/kg
ethanol produced brain concentrations of methadone of 62 ng/g ±. 13

and 140 ng/g ±. 25 respectively. Thus, even though a 4.� g/kg dose of

ethanol produced higher brain and serum levels of ethanol than 2.5 g/kg,

the effect on methadone concentration in the brain is the same.

2) Changes in Absorption and Distribution to Peripheral Tissues
In order to investigate the reasons behind the decreased brain

level of methadone when combined with ethanol, studies of the effects

of ethanol on the absorption of methadone from the subcutaneous injection

site and the distribution of methadone to other tissues were conducted.

The injection site and underlying musculature were excised and washed

twice with 0.5 N' HCl. An aliquot of the acid was mixed with Aquasol-2

and raidoactivity was measured. It was found that 30 minutes after

a 4.0 mg/kg dose, 90 and 92% of the dose had been absorbed from the

injection sites in ethanol and water-pretreated animals respectively.

Another possible reason for decreased concentrations of methadone

in brain was an ethanol-induced increase in distribution of methadone to
other tissues. Levels of 3H-methadone in brain, serum, liver and lung

were detennined at various times after a 4.0 mg/kg dose of methadone

following either water or ethanol (2.5 g/kg) pretreatment. The results
of these detenninations are presented in table 4. As observed in the

dose-response experiment (table 3), ethano'l produced a significant decrease
in brain and serum methadone compared to control animals. However, this

TABLE 4

Tissue

THE EFFECT OF ETHANOL ON THE DISTRIBUTION OF METHADONE
AND UNCONJUGATED METABOLITES
ETOH

30

Time After Methadone Administration(l) (Min.)
90

150

ETOH

2.66 .±. .10**

5.41 .±. .25

.71:J:_.ll*

l.05 .±. . 06

6. 41 .±. .31

o.92 .±. .1a

, ., 6 .±. . , o

Brain
Tota1(2)

8.19 .±. .37**

11 .2 .±. .07

Serum
Total

8.81 .±. .20**

13.6 .±. 0.9

3.29 .±. .25* *
1
10.5 .±. 0.7 2.51 .±. .09**

5. 00 .±. . 35

0.70 .±. .12

265 .±. 19

201 .±. 23

, 25 + 15

348 .±. 21

338 .±. 25

Methadon/ 3)

Methadone

Liver
Total

Methadone

Lung
Total

Methadone

6.96 .±. .31**
7.05 .±. .25**
92.6 .±. 12
31 o .±. 19

9.7 .±. 0.6

80.3 .±. 11

301 .±. 22

1

1

I

Control

Control

ETOH

Control

3.20 .±. .12**.

149 + 13

59.6 .±. 3.7

49.8 .±. 3.l

105 .±. 7.4

99.l .±. 6. 5

88.9 .±. 6.3

. 94 .±. .15*

6.49 .±. .30

80.3 .±. 5.3

I

1.31 .±. .07

ETOH
1

210

0.58 :1:_.09

Contro1

o. 63 .±. .03

0.44 .±. . 07

0.49 .±. . 02

0.59 .±. .08

0.48.±_.04

62. , + 3.,

56.0 + 15

36.5 + 2.5
1
23.7 .±. l .8 15.0 .±. 1 .8

42. l .±. 4.1

52.0 .±. 3.9

44. 1 .±. 5. 6*
1
36.2.±_4.2 35.3 .±. 4.5*

30.9 + 2.8

25., .±. l.3

41.1 .±. 3.1

0.83 + .07

45.3 .±. 5.3

I

0.43 .±. .06

0.35 .±. .03

13.l .±. 2.8

24.7 .±. 2.2

(1). Ethanol or water was administered p.o. 30 minutes before Methadone, 4 mg/kg s.c.
(2). Values are extractable DPMXl0-3/g of tissue wet weight _±_SEM, N = 6 animals/group.
( 3). Unmetabolized Methadone was calculated by correcting total extractable 3H for the% which migrated
with Methadone on TLC as described in Methods.
* different from control at P<.05

;** different from control at P(.01

tJ'1
f-'

was not accompanied by uniform significant increases in either liver
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or lung concentrations of methadone although at each time point invest
igated the ethanol-pretreated mice had slightly greater methadone con
centrations in these tissues. This finding agrees with the data on
subcutaneous absorption since, if ethanol decreased brain-methadone
concentrations only by decreased absorption, then liver and lung con
centrations would be expected to be lowered also. \.Jhen liver and lung
concentrations of methadone were examined in relation to the serum
concentration of methadone perfusing them, ( tab 1 e 5) it vias seen that
ethanol pretreatment produced a significant increase in hepatic and
pulmonary uptake of methadone.
In this experiment, as in all others where the brain/serum distri
bution of methadone was examined, both brain and serum were found to
contain approximately,equal concentrations of methadone. The only excep
tion was in the dose-response experiment (table 3) where 4 mg/kg
methadone in control mice gave a brain/serum ratio of 1.6. However,
the experiment presented in table 4 shows that with this dose at 30
minutes post methadone, the brain/serum ratio is 0.92, indicating that
there is probably no real d6se-dependent alteration in methadone distri
bution between brain and serum.

The relative amounts of total 3H to 3H-methadone in brain and serum

shown in table 4 are representative of the ratios determined in other

experiments. There was no alteration in the relative amounts of 3H

methadone to metabolites in brains from mice treated with 0, 2.5, or
4.0 g/kg ethanol. These ratios were used to calculate methadone concen
tration from total extractable 3H values as described in methods. As
expected, the liver contained the greatest relative amount of methadone
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TABLE 5
EFFECT OF ETHANOL ON LIVER/SERUM AND LUNG/SERUM
METHADONE RATIOS

Time After Methadone Administration (min)
30

90

150

210

Ethanol

13.1 + 1. 5*

23.7 + 4.8*

35.9 .±:_ 4.1

34.9 + 3.2

Control

7.6.±:_1.0

9.96 + 1.2

28.6 + 3.2

37.4 + 3.6

Ethanol

43.8 + 4.8*

35.4 + 4.3**

58.7 + 4.1*

82.1 + 4.9

Control

28.7 .±:_ 3.2

16.1 + 2.0

43.6 .±:_ 5.1

70.6 + 10.3

Liver/Serum

Lung/Serum

Values are the ratios of methadone concentrations from Table 4.

· *Significantly different from control at P <.05
**Significantly different from control at P (.01

metabolites of the tissues examined.
D)
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Correlation Between Brain Concentration of Methadone and Antinoci
ceptive Effect
In view of the effect of ethanol on the amount of methadone in

the brain, a brain concentration-response curve may be a more valid
measure of ethanol potentiation of methadone antinociception than
the dose-response curve. The least square lines relating brain methadone to effect in animals administered methadone 15 minutes and 60
minutes prior to testing were colinear and therefore, the data from
both dose-response c urves was used to construct the concentration-

response curves presented in figure 7. The concentration-response curve
for 4.0 g/kg ethanol was obtained 15 minutes post methadone.
In all three cases, pretreatment with water, 2.5 or 4.0 g/kg
ethanol, there is a _very high correlation between whole brain methadone
and antinociceptive effect.

The correlation coefficients are 0.94,

0.92 and 0.89 respectively. At any given brain concentration of methadone the antinociceptive effect is greater in ethanol pretreated mice.
The Litchfield and Wilcoxon EC50•s for control, 2.5 g/kg and 4.0 g/kg
ethanol treated mice are presented in figure 7. Ethanol pretreatment
with a 2.5 g/kg dose produced an approximate threefold parallel shift
in the concentration-response curve while pretreatment with 4.0 g/l<g
produced an additional threefold shift to the left. These data show
that the increased antinociceptive activity of methadone in ethanolpretreated animals was not due to an increased methadone concentration
in brain.

FIGURE 7.
CORRELATION BETWEEN BRAm CONCENTRATION OF METHADONE AND TAIL-FLICK ACTIVITY
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Ethanol ( 2.5 or 4.0 g/kg, p.o.) or water was administered 60 minutes prior to test.
Methadone was administered s.c. 15 or 60 minutes prior to test. Brain methadone levels
were determined by liquid scintillation. N = at least six mice/group.
• +=points from the dose response curve 60 minutes post methadone
all other points are from the dose response curve at 15 minutes post methadone
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Effect of Ethanol on the Time Course of Methadone Antinociception
1) Time course following subcutaneous administration
Mice were adminstered either water or ethanol and injected

with methaJone 30 minutes later.

The effects of ethanol on methadone

antinociception and brain level are presented in figure 8. As was
found in the dose-response studies, ethanol-pretreated mice had lower
brain concentrations of methadone but exhibited a greater antinoci
ceptive response at every time point studied. Animals tested and
sacrificed at 210 minutes were also tested for antinociception at
60 minutes post methadone.

Brain concentrations of methadone were

lowered to approximately the same extent as found in the dose-response
experiments.

In addition, the relationship between brain level and

antinociceptive effect both with and without ethanol was similar to
that presented in ffgure 7.
Since the antinociceptive response to methadone alone at 4 mg/kg
was greater than 60% MPE for 60 minutes and the maximum possible effect
is 100% MPE the potentiation of methadone by ethanol is better examined
at lower doses of methadone.

In figure 9 mice were orally dosed with

ethanol and then immediately administered methadone (2 mg/kij) subcu

taneously.

In this case the effect of methadone and ethanol was greater

than methadone alone throughout the time course investigated.

The

degree of potentiation seemed greatest at 60 minutes following methadone.
Since the brain level and effect of both ethanol and methadone were
changing during this experiment, potentiation was studied under condi
tions where the effect of ethanol was constant.
Results of the administration of ethanol at a uniform 60 minutes
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FIGURE 8.
EFFECT OF ETHAfWL Ofl THE TIME COURSE OF TAIL-FLICK ACTIVITY AND
THE CONCENTRATION OF METHADONE IN BRAIN
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Water or Ethanol(2.5 g/kg, p.o.) was administered 30 minutes prior
to methadone. Brain levels determined by liquid scintillation.
Each point represents the mean + SEM of six mice.
* significantly different from control at P �.05
** significantly different from control at P <.01

FIGURE 9.
EFFECT OF ETHANOL OH SIMUL TAi·lEOUSL Y ADMINISTERED
METHADOME
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\rlater or ethanol (2.5 g/kg, p.o.) administered at same
time as methadone (2 mg/kg, s.c.). Brain levels of
methadone were determined by liquid scintillation.
Each point represents the mean+ SEM of at least six mice.
** significantly different from-control at P <.01

FIGURE 10
THE TIME COURSE OF METHADONE TAIL FLICK ACTIVITY WHEN ETHANOL IS
ADMINISTERED 60 MINUTES PRIOR TO TESTING
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Methadone (2 mg/kg) was administered s.c. and animals were tested at
various times thereafter. In all cases either ethanol (2.5 g/kg, p.o.)
or water was administered 60 minutes prior to testing. Brain methadone
was determined by liquid scintillation. There were at least 6 mice/group.
·** significantly different from control at P(.01
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prior to testing and at various times after subcutaneous dose of
methadone (2 mg/kg) are presented in figure 10.

In this protoco1

the points at 15 minutes post methadone represent mice dosed with
ethano1 or water 45 minutes prior to methadone and tested 15 minutes
after methadone.

si�ilar1y, the points at 105 minutes post methadone

represent mice administered methadone 45 minutes prior to ethano1 or
water and tested 60 minutes 1ater.
The data on brain concentrations of methadone indicate that, as
before, when ethanol was administered prior to methadone, the ethanol pretreated mice achieved lower methadone 1eve1s than their water
pretreated controls.

However, when methadone was administered con

comitantly or prior to ethanol, the two groups achieved similar brain
concentrations of methadone.

When the antinociceptive response is cor

rected for a1terations in brain methadone level between the two groups,
ethanol produced an approximate twofold increase at al1 time periods
with the exception of 60 minutes post methadone. As in figure 9, the
re1ative potentiation seems to be greatest when ethano1 and methadone are
administered simu1taneously and tested at 60 minutes post methadone.
Since the antinociceptive effect is on a binomia1 scale, the. ratio of
effect with ethanol/effect without ethanol is not the best way to
gauge relative potency.

In order to determine if the potentiation at_

60 minutes post ethano1 and methadone is greater than at other time
intervals, the dose response curves in figure 11 were determined.
In this experiment, ethano1 (2.5 g/kg) was administered oral1y
and various subcutaneous doses of methadone were administered at the
same time.

In this protocol the potency ratio between methadone a1one,
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FIGURE 11.
THE EFFECT OF ETHANOL ON THE TAIL-FLICK ACTIVITY OF
SIMULTAilEOUSLY ADMIMISTERED METHADONE
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methadone and mice were tested 60 minutes later. N c six/group.
Control ED50 = 2.8 (1.8-4.5) with ethanol ED50 = 1.0 (0.6-1.6)
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and ethanol and methadone was 2.8 whereas the potency ratio 15
minutes post methadone with a 45 minute ethanol pretreatment was
2.5 (figure 5).

The differences in potency ratio as well as diff

erences in ethanol or water pretreated ED5o's between these two
experiments were not significant. The concentrations of methadone
in the brain and serum from these mice are presented in table 6.
When ethanol and methadone were administered simultaneously, the
brain concentration of methadone in ethanol-treated and control
mice were generally similar.
In order to investigate whether the ability of ethanol to
potentiate methadone declines more rapidly than brain-ethanol levels,
three groups of mice were treated with 2.5 g/kg ethanol 90 minutes
before subcutaneous administration of methadone (2 mg/kg) and tested
at 60, 90 and 120 minutes post methadone (i.e. 150, 180 and 210
minutes post ethanol) when the estimated brain ethanol levels would
be 140, 116, and 92 mg/100 g respectively. The data presented in the
first two horizontal lines of table 7 show that ethanol is able to
potentiate methadone as well at 150-210 minutes post ethanol as it is
at 60-120 minutes. The decreased antinociceptive effect between the
above treatments is probably solely due to the lesser ethano1 levels
during the test interval when ethanol is administered 90 minutes prior
to methadone, rather than simultaneou�ly with methadone.
2) Time course following oral administration
Since in most human use of ethanol and methadone the route of
administration is oral rather than parenteral, interactions were also
studied following this route of administration. Figure 12 presents the
results of oral administration of ethanol or water 30 minutes prior to

TABLE 6
EFFECT OF ETHANOL ON BRAIN AND SERUM METHADONE CONCENTRATIONS
Dose of Methadone
m /k (s. c.)

Ethanol Pretreatment
% MPE b Methadone Level
ng/g + SEM
- Serum
Brain

0.5

12

37+10
-

43+8
-

1. 0

43

63+12

109±_14

2.0

80

168±_18

170±_23

3.0

--

4.0

95

--

374±_28

--

397±_39

\·later Pretreatment
% MPE b

--

Methadone Level
ng/q + SEM
Brain - -serum

I

Ratio of
Brain Levels a.

--

--

8

89+10

111+12

I

o. 71

12

154+16

137+12

I

1. 09

45

281+36

302+53

65

387+43

387±_50

I

0.97

Ethanol (2.5 g/kg, p.o.) or water was coadministered with methadone. Methadone levels
were determined by liquid scintillation. l·l� six mice/group.

aRatio of brain concentration of methadone in ethanol pretreated mice/water pretreated mice
bAntinociceptive effect in the tail-flick test.

a,
w
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TABLE 7
COMPARISON OF SIMULTANEOUSLY ADMINISTERED ETHANOL WITH
90 MINUTE ETHANOL PRETREATMEl'/T
% MPE in the Tail-Flick Test
Time Post Methadone (min)

60

90

120

Ethanol and Methadone
Coadministered (figure 9)

90

40

10

Ethanol 90 minutes before
Methadone

67

36

10

Water and Methadone
(figure 9)

There were at least six mice per group.

10
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FIGURE 12
EFFECT OF ETHANOL ADMINISTERED BEFORE METHADONE
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Ethanol (2.5 or 4.0 g/kg, p.o.) or water was administered 30
minutes prior to methadone (8 mg/kg. p.a.). Each point represents
the mean:!:_ SEM of at least six mice per group.
* significantly different from control at P (.05
** significantly different from control at P <.Ol

oral administration of methadone.
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Since the mice had been deprived of

food for 16 hours prior to drug administration, the absorption of metha
done was rapid in the control animals.

A significant antinociceptive

effect was noted as early as 7 minutes after methadone was administered.
Mice tested at 7 minutes were retested and sacrificed at 120 minutes.
Mice tested at 150 minut es were retested and sacrificed at 210 minut es.
In control animals peak concentrations of methadone in brain were
achieved at 30 minutes post methadone. Pretreatment with ethanol seemed
to delay tl1e initial ·absorption of methadone but at times after 60
minutes the ethanol-pretreated animals had a greater methadone concen
tration in brain than the control animals.

As was noted following

subcutaneous administration, the effect of ethanol on the concentration
of methadone in brain was not dose related.

The effect of 4-.0 g/kg

ethano 1 on who 1e brain .. concentrations of methadone was the same as 2.5
g/kg ethanol. However, the increase in antinociceptive response is
dependent upon the dose of ethanol administered. There was once again
a strong correlation between brain methadone and antinociceptive response
in all three groups. Since there was significant alteration in the
specific activity of 3H-methadone following oral administration, all
brain levels, although still corrected for the amount of metha3one meta
bolites present, are reported as OPM/g (see appendix 1).
Although some of the alterations in the concentration of methadone
in the brain following this route of administration are presumably due
to the same effect noted following subcutaneous administration, there
seems to be an additional effect of ethanol upon the absorption of orally
administered methadone. To invest1gate this, the amount of methadone
remaining in the stomach at various times after administration was deter-
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mined.

As can be seen in table 8, there is a rapid loss of methadone

from the stomach in control animals. The loss of methadone is delayed
following a dose of 2.5 g/kg ethanol.

The same delay is observed

following pretreatment with 4.0 g/kg ethanol.

This loss of methadone

from the stomach reflects the sum of absorption from the stomach as
well as emptying of the stomach contents into the small intestine.

The

effect of ethanol outlasts the presence of ethanol in the stomach since
by 60 minutes following both 2.5 and 4-.0 g/kg doses, approximately 95%
of the ethanol had left the stomach.

Thus, in addition to the effect

of ethanol on methadone once it is absorbed, ethanol also causes an
initial delay in methadone absorption following oral administration.
In order to examine the potentiation of orally administered metha
done without these significant alterations in the concentration of metha
done in brain methadone was administered orally 30 minutes prior to
ethanol. At this time approximately 90% of the methadone dose had left
the stomach and thus alterations of the absorption of methadone would be
expected to be less.

Figure 13 shows that with this dosing protocol

there were no significant alterations in the amount of methadone in brain.
F)

The Effect of Food Deprivation on Methadone Antinociception
To investigate the possibility that the ethanol potentiation of

methadone antinociception is mediated by its ability to alter blood
glucose levels, experiments in which the nutritional status of the mice
was changed were undertaken. The results of these manipulations are
presented in table 9.
Administration of ethanol to free-feeding mice would be expected to
slightly elevate blood glucose concentrations (7) however, administration
of isocaloric glucose (71) instead of ethanol did not alter methadone
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TABLE 8

EFFECT OF ETHANOL ON THE LOSS OF METHADONE FROM THE STOMACH
Time After Methadone
(8 mg/1,g, p.a.)
30

H2o group
9.6

% of Dose in the Stomach
4.0 g/kg group
2.5 g/kg group
22

60

19.6
18.5

90

4.8

17

120

0.8

9.9

150

1. 4

14. 7
4.8

Ethanol was administered (p.a.) 30 minutes •prior to methadone.
N = six mice/group.
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FIGURE 13
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TABLE 9
THE EFFECT OF FOOD DEPRIVATION ON METHADONE ANTINOCICEPTION

Treatment

ED50

(95% C.I.)

food and water ad. lib. + water
food and water ad. lib.+ ethanol
food and water ad. lib. + glucose

3.7
1.3
3.5

(0.8 - 2.2)

deprived of food+ water
deprived of food+ ethanol
deprived of food+ glucose

2.8
l. 0
2.3

(1. 8 - 4.5)
(0.6 - l.6)
(l. 5 - 3.5)

(2.6 - 5.3)

(2.3 - 5.3)

Ethanol (2.5 g/kg, p.o.) or glucose (5.13 g/kg, p.o.) was simultaneously
administered with methadone (s.c.). The ED5o's for mice deprived of food
with and without ethanol are from figure 11. The methadone+ water, and
glucose dose-response curves were based on methadone doses of 2,3 and 4
mg/kg (s.c.). The dose response curves with ethanol were based on methadone
doses of 0.5, l, and 2 mg/kg. There were five mice/dose.
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antinociception in either free-feeding mice or food-deprived mice.
In addition, ethanol produced an approximately equal shift in the
rn50 of methadone in both free-feeding and food-deprived mice.

Methadone seemed to be less potent in free-feeding mice but the

Eo 50 1 s in free-feeding and food-deprived mice were not significantly

different.

Thus, since ethanol produced a similar shift in the ED50 of

methadone in both deprived and free-feeding mice and substitution of
isocaloric glucose was without effect in both states, the ethanol
induced alteration of antinociceptive response is not an artifact of
food deprivation and furthermore, is not a reflection of the effect of
ethanol on the nutritional status of the mice.
G) Effect of Methadone on the Concentration of Ethanol
Since it was show� in table 2 that high concentrations of ethanol
could increase tail-flick latency, another possible mechanism of the
observed potentiation involves not the elevation of brain methadone by
ethanol, but the elevation of brain ethanol by methadone.

The results

of bra in-ethano 1 determinations in mice dosed orally with ethano 1 in
combination with either methadone or water are presented in fi9ure 14.
Both drugs were given by the same route of administration to increase

the possibility for interaction.

Table 8 shows that using this dosing

schedule at least 10% of the methadone dose was still in the stomach

when ethanol was administered.

Since the brain concentration of ethanol when combined with
methadone is similar to the ethanol concentration obtained when ethanol
is administered alone, and these concentrations of ethanol are without
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FIGURE 14.
THE EFFECT OF METHADOfff ON BRAIN CONCENTRATION OF
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Methadone (8 mg/kg, p.o.J or water was administered 30 minutes
prior to ethanol (2.5 g/kg, p.o.). Each point represents the
mean+ SEM of at least five mice. Brain ethanol was determined
by GLC. * significantly different from ethanol alone at P <.05
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significant effect on tail-flick latency (table 2), none of the
increased antinociceptive effect of ethanol and methadone combinations
can be attributed to a simple elevation of the brain concentration of
ethanol.
In addition to the data in figure 14, the effect of methadone on
ethanol concentrations was also studied in Sprague Dawley rats as shown
in table 10. Methadone administered intraperitoneally in doses up to
4.0 mg/kg did not alter the whole brain or whole blood concentrations of
ethano1 compared to a·nima1 s that received the same ora 1 dose of ethano1
alone.

The effect of methadone in this case would be expected to be

sma11 sinee ethano 1 was administered 45 minutes prior to methadone and
animals were sacrificed only 15 minutes after methadone. However, since
this is the same dosing schedule used in the dose-response curves
presented in figure 6,., it shows that the observed increased activity
of ethanol and methadone combinations in rats is not due to alterations
of brain ethanol levels.
H) Effects of Ethanol on the Excretion of Methadone Metabolites and on
the Half-Life of Methadone in Brain
To assess the impact of ethanol administration on the metabolism
and excretion of 3H-methadone, the relative amounts of methado'ne and its
metabolites in bile and urine were determined by TLC analysis.

In that

the samples were not hydrolyzed prior to solvent extraction, these results
deal only with alterations in the amounts of unconjugated metabolites.
As can be seen in table 11, the urine, after subcutaneous administration
of methadone contains approximately equal concentrations of methadone
and EDDP and very little EMDP while bile contains almost equal concentrations of all three substances.

When methadone is administered orally
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TABLE 10
EFFECT OF METHADONE ON ETHANOL CONCENTRATIONS
rn RATS

Methadone dose
mg/kg i. p.

Whole Blood Level
mg/100mg ±. SEM

0

1 69

2.0

177 + 26

3.0

174

4.0

163 + 36

+

+

59

Brain Level
mg/lOOg ±. SEM
38

161

+

158

±. 27

31

Ethanol (2.5 g/kg, p.a.) was administered 45 minutes prior to Methadone.
Levels of Ethanol were determined 15 minutes after Methadone.

TABLE 11

EFFECT OF ETHANOL ON UNCONJUGATED METHADONE METABOLITES
IN BILE AND URINE

Pretreatment

Methadone --------- URINE
Administered Methadone :EDDP

Ethanol

s.c.

l•/ater

Ethanol

Water

s.c.

I

p. o.

p.o.

* I
*
44. 3 :I'_ 8.1 I s3. 3 .:t:_ 9.1
**
45.7.:t:_12 149.8:!:_12
.

11.6 :!:_ 2.3

-

10.2 + 1.2
1

186.5 :!:_ 3.2

EMDP

3.1 .:t:_ 1. 2

5.2:!:_2.0
2.5 :!:_ o.6

Methadone

:

EMDP

I
*
20.7 .:t:_ 3. 2 144.8 :!:_ 8. 1 I 34.6 .:t:_ 6.7
20.8:!:_ll !51.8:!:_ll 127.5:::_4.6
I

10.2 :!:_ 1.6

I:i 84.5 + 3. 7**
,. s. 7 -+ 3. 1 I I1 10 -+ 2.9
,' I
l

I

BILE
EDDP

I

58.6 :!:_ 5.3 I 31.2 .:t:. 5.1
I
64. 7 + 3. 9 Ii 25.1 + 2.9
.'

-

Values are expressed as percent of total radioactivity present as each metabolite :t:_ SEM.
Bile and urine were collected at time of sacrifice 60 to 120 minutes after administration
of methadone 8 mg/kg, p.a. or 2 mg/kg, s.c. N = at least 18 mice/treatment. Samples were
pooled in groups of three.

*
**

significantly greater than mice dosed by other route of administration at P <.05
significantly greater than mice dosed by other route of administration at P <.01

"-J
"1

·-
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the metabolism of methadone is apparently enhanced as evidenced
by the significantly greater relative amount of methadone meta
bolites after this route of administration.
There was no significant ethanol-induced alteration in the
relative proportions of methadone and its metabolites.

The observed

alteration of metabolites following different routes of administration
serves as a positive control and shows that alterations in the rate
of metabolism could be detected.

Other than EDDP and EMDP, no other

3fH abe 1 ed methadone metabo 1 ites were detected in either bile or
urine.

Figure 15 shows that the ill vivo half-life of methadone in brain
is not altered by pretreatment with 2.5 g/kg of ethanol. Tl1e half
life in control mice is 45 minutes and in ethanol-pretreated mice is
39 minutes. The brain. level data in this figure were taken from
figure 8. The dose of methadone was the same in both ethanol and water
pretreated mice but as noted previously, the ethanol-pretreated animals
displayed a lower concentration of methadone in brain than the control
mice.

In the course of brain and serum 3H-methadone determinations, the

ratio of methadone to total methadone plus metabolites was determined
as described in methods.

In no experiment was a significant difference

in this ratio observed between ethanol and water treated mice (for example,
see table4).
If there were qualitative or quantitative alterations in methadone
metabolism these changes would be expected to be most easily observed in
the liver where the concentration of the drug is higher and where most
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FIGURE 15
WHOLE BRAIN HALF-LIFE OF METHADONE FOLLOWING A
4 mg/kg, s.c. DOSE IN NAIVE MICE
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Water or ethanol (2.5 g/kg, p.a.) was administered 30 minutes prior
to methadone. Brain levels of methadone were determined by liquid
scintillation. Each point represents the mean! SEM of six mice.

of the metabolism occurs.

78

The results of the analysis of methadone in

liver are presented in table 12.
The relative amounts of methadone, EDDP and EMDP are almost identi
cal in animals dosed subcutaneously or orally, with and without ethanol
pretreatment.

The greater relative amount of EDDP noted in the urine

of animals dosed orally is explained by the significantly greater liver/
brain ratio in these animals. The 3H which was not extracted from the
homogenate represents the sum of water soluble metabolites of methadone
and any lipid soluble metabolites of methadone not extracted by the
solvent.

Studies with authentic methadone, EDDP and EMDP indicate

that approximately 5% of these compounds are not extracted by the pro
cedure employed. The significantly greater percentage of non-extracable
3H in animals dosed orally is probably caused by exchange of label
following this route of administration (see appendix I) rather than
an increase in the formation of water soluble metabolites.
The routine TLC procedure did not reveal any 3H other than that in
the zones corresponding to methadone, EDDP and EMDP. To see if other
metabolites were formed, the liver samples following oral administration
of methadone were further analyzed in two iTLC systems using silica
gel impregnated fiberglass sheets as described in methods.

E�en in

these systems no evidence for the formation of additional metabolites
in either control or ethanol-pretreated mice could be found.

It is

possible that other known metabolites of methadone could have been formed
but lost in extraction or TLC steps or not detected due to the low
specific activity of methadone employed.
Of particular interest are the reduced metabolites of both g_ and

TABLE 12
EFFECT OF ETHANOL ON METHADONE METABOLITES
IN THE LIVER
Pretreatment

Methadone
Administered

Methadone

EDDP

EMDP

Non-Extractab1e
3H

Liver/Brain
Methadone

Ethanol

s.c.

. 38 + .05

.34 + .06

.14 + .03

. 15 + .05

28.9 + 4.5

Water

S. C.

.35 + .06

.33 + .09

.13 + .03

.19 .±. . 04

21.0 + 6.9

Ethanol

p.a.

.30 + .03

.29 + .06

.10 + .02

.31 .±. .05

62.7 + 10. 7

Water

p.a.

.28 + .07

.25 + .05

.12 + . 06

.35 + .07

55.5 + 7.1

**
**

Results are expressed as the ratio of methadone or metabolite DPM to the tota1 DPM/g of
liver(+ SEM) 60 minutes after the methadone dose as described in Methods. Ethanol or
water administered p.a. 30 minutes prior to methadone (8 mg/kg, p.a.) or simultaneous1y
witn methadone(2 mg/kg, s.c.). N= 12 mice/group.

**

significantly different from mice dosed s.c. at P <.Dl

-..J
<D
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l-methadone, alpha-1-methadol and alpha-.s!_-methadol (152) respectively.

Although alpha-.s!_-methadol is not an active metabolite, alpha-1-methadol
possess antinociceptive activity of the same order of magnitude as
.s!_,l:-_methadone

(152).

Since the administration of ethanol produces a

marked increase in the NADH/NAD ratio in the liver (87), it is possible
ethanol would also increase the production of these reduced metabolites.
I) The Effect of Ethanol on the Antinociceptive Activity of ]-Methadone
� and Other Narcotics
Rather than go through an extensive search for the reduced metabolites of methadone, their possible role in the ethanol-mediated poten
tiation of methadone antinociception was evaluated by combining ethanol
and ]-methadone.

If increased production of reduced metabolites of

methadone is a reason for increased antino_ciception from .sl_,l-methadone
then ethanol would be unable to potentiate the action of l-methadone
since its reduction metabolite possesses almost no antinociceptive activity.
The results of this experiment are presented in figure 16.

As would

be expected, the control ED50 of l-methadone is approximately one-half
that of .s!_, l-methadone. More interestingly, simultaneous administration
of

2.5

g/kg of ethanol produced a significant potentiation of l -metha

done antinociception, reducing the ED50 from 1.4 mg/kg to 0.6 mg/kg.
The results of combination of ethanol and other narcotics are

presented in Appendix II.
J)

Antagonism of the Tail-Flick Activity of Ethanol and Methadone by
i�a 1 oxone
If the increased antinociceptive effectiveness of combinations of

methadone and ethanol is due to a true potentiation of the narcotic
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FIGURE 16
THE EFFECT OF ETHANOL PRETREATMENT ON THE TAIL-FLICK
ACTIVITY OF 1-METHADONE
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Ethanol (2.5 g/kg, p.o.) or water was coadministered with methadone
and animals were tested 60 minutes later .. N = at least six mice/group
Control EDso= 1.4 (0.9-2.2), with ethanol ED50= 0.6 (0.4-0.9)

agonist properties of methadone by ethanol then this effect should.
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be antagonized by a specific narcotic antagonist such as naloxone. To
test this, 36 mice were treated with 2.5 g/kg ethanol 45 minutes prior
to subcutaneous administration of 1.3 mg/kg methadone. Another group
of mice was pretreated with water and administered 3.6 mg/kg methadone
subcutaneously.

Twelve mice from each group were tested for tail-.

flick latency 15 minutes after methadone. These mice also received
subcutaneous saline 30 minutes prior to testing. The mice treated
with ethanol and methadone had an average concentration of methadone
in the brain of 245 ng/g :!:. 32 and an antinociceptive effect of 74%
MPE. The animals which received 3.6 mg/kg methadone had an average
concentration of methadone in the brain o�740 ng/g :!:. 27 and an antin
ociceptive effect of 86% MPE.
The remaining mice were administered various doses of naloxone
instead of saline and tested for tail-flick latency in order to est
ablish the dose-response curves presented in figure 17. The mice which
received 0.05 mg/kg naloxone had an average brain-methadone level of
276 ng/g :!:. 19 and 702 ng/g :!:. 37 in the ethanol and methadone, and metha
done alone groups respectively.
To assess the effect, if any, of naloxone on the tail-flick activity
of ethanol, the highest dose of naloxone used, 0.05 mg/kg was combined
with high doses of ethanol (table 13). Although 6.0 g/kg ethanol pro
duced a significant elevation of tail-flick latency, this effect was
not altered by naloxone.
Despite the lack of effect of 0.05 mg/kg naloxone on ethanol alone,
naloxone at this dose was able to produce an almost 90% reduction in the

FIGURE 17
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ANTAGONISM OF THE TAIL-FLICK ACTIVITY OF ETHANOL
AND METHADONE BY NALOXONE
e---11 Methadone
lll--fll Methadone+ Ethanol
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Animals were pretreated with either ethanol (2.5 g/kg, p.a.) or
water at Time = 0, injected with naloxone at T=30 min., injected
s.c. with 1.8 or 3.6 mg/kg methadone respectively at T=45 min.
and tested at T=60 min. N = 6 mice/group.
1050 against Methadone = 0.032 mg/kg (.021 - .049)
ID50 against Ethanol and Methadone = 0.026 mg/kg (.019 - .035)
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TABLE 13
EFFECT OF NALOXOIIIE ON THE TAIL-FLICK ACTIVITY OF ETHANOL

Dose of Etha no1
g/kg, p.o.

Brain Level of
Ethanol
mg/1 OD g :1:. SEM

%MPE
with saline

%MPE
with O. 05 mg/kg
Naloxone s.c.

2.5

193

+

7

2.0

4.0

312

+

25

-4.1

1.2

6.0

500

+

45

85

73

Mice were administered ethanol 30 minutes prior to naloxone and
tested 30 minutes later. There were five animals/group.
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antinociceptive effect of ethanol and methadone.

In addition, as

shown in figure 17, naloxone antagonized ethanol and methadone in
the same manner as it antagonized methadone alone. That is, although
the mice administered ethanol and methadone had much lower brain
methadone levels compared to the mice administered methadone alone,
the slopes of the dose-response curves as well as the calculated Io50•s
were identica 1 in both groups.
K) Effects of Ethanol in Methadone-Tolerant Mice
Since the combined use of ethanol and methadone in humans most
frequently occurs in methadone maintenance patients who are tolerant
to methadone it is important to investigate the effects of the combin
ation in a chronic as well as in an acute situation. To do this, mice
were made to 1erant to methadone by once daily admini stration of methadone
at a constant oral dose of 20 mg/kg.
Since the half-life of methadone in the brain of mice following
subcutaneous administration is less than 1 hour it was thought that the
dose would have to be increased or administered more frequently to pro
duce tolerance.

To monitor tolerance, groups of six mice were tested

for tail-flick activity and brain concentration of methadone _during
the course of the 20 mg/kg/day treatment. As shown in figure 18, after
four doses of methadone the antinociceptive activity of methadone was
reduced by half although brain methadone was only slightly decreased
compared to the results of the first dose.

It was therefore thought that

tolerance would develop even at a daily dose of 20 mg/kg and this dose
was continued.

Figure 18 Shows that after 3 days (or eight 20 mg/kg doses)

the brain concentration of methadone 60 minutes after a 20 mg/kg dose
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had significantly declined from 650 ng/g to 400 ng/g and the
antinociceptive effect had declined from 85% MPE to 25% MPE.
Thus, chronic methadone administration had apparently induced its
own metabolism but the fact that the antinociceptive effect declined
more rapidly than the brain concentration of methadone indicates
some ms tolerance to methadone.

A parallel group of twelve mice

were tested for physical dependence 24 hours after their eighth
dose of methadone (20 mg/kg/day). Subcutaneous injection of naloxone
at 3 or 9 mg/kg did not precipitate any jumping in these mice.

Naloxone

did produce signs of hyperventilation and increased urination and
defecation. Analysis of the brains from these mice by GC/MS failed to
reveal any residual methadone.

Considering the sensitivity of the GC/

MS assay, this indicated that if any free methadone existed in the brain
at this time it was at a level less than 5 ng/g.
The effect of the daily administration of methadone at a dose of
20 mg/kg on body weight and locomotor activity was also determined. As
can be seen in figure 19, the first dose of methadone produced a signi
ficant elevation in locomotor activity.

Tolerance to this effect was

rapid and by the third dose there was no elevation in locomotor activity
compared to control animals.

The methadone treatment produced some

decline in bociy weight but the alteration was not significant.

Since the animals maintained on methadone had free access to food

and water at all times, the absorption and antinociceptive activity of
an oral dose of methadone in free-feeding naive mice was investigated.
Figure 20 shows the whole brain concentrations of methadone and the an
tinociceptive effect of methadone in these animals. Animals tested and
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FIGURE 19

THE EFFECT OF METHADONE ON BODY 'WEIGHT AND LOCOMOTOR ACTIVITY
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Brain levels

90
sacrificed at 210 minutes were a1so tested at 90 minutes post methadone.
In order to investigate whether the to1erant mice would sti11 dis

play an increased antinociceptive effect if the brain concentration of
methadone was increased, mice maintained on 20 mg/kg/day were admini

stered 40 mg/kg methadone (figure 21). This dose of methadone in tol

erant mice produced a brain concentration of methadone a1most equa1 to
the concentration obtained fo1lowing a 20 mg/kg dose in naive mice and

greater than that following the norma1 maintenance dose of 20 mg/kg.

The tolerant mice did derive a greater antinociceptive effect from these
increased methadone concentrations since at 60 minutes these mice

disp1ayed 70% MPE while mice maintained on 20 mg/kg displayed 25%
MPE.

Mice tested at 15 and 60 minutes were retested and sacrificed

at 150 and 90 minutes respective1y.

The effect of water or 2.5 g/kg ethanol administered 30 minutes

before the eighth methadone dose of 20 mg/kg is presented in figure 22.

At 30 minutes both groups had identical brain concentrations of methadone.

At later time periods the ethanol-pretreated mice had brain concentrations
of methadone greater than control. To compare the effects of ethano1

on brain methadone and antinociception, the areas under the correspond
ing curves were integrated from 30 to 150 minutes post methadone (table

14). These results indicate that although ethano1 pretreatment in

to1erant mice produced a 35% greater brain level, it increased the

antinociceptive response by 367%. A 40 mg/kg dose increased brain metha
done by 70% compared to 20 mg/kg with ethano1 in tolerant mice but stil1

produ·ced an antinociceptive response 13% 1ess. Thus, a1though ethanol

in free-feeding, methadone-to1erant mice produced s1ightly greater brain

FIGURE 21
TAIL-FLICK ACTIVITY AND BRAIN-METHADONE LEVELS IN
TOLERANT MICE (40 mg/kg, p.o.)
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THE EFFECT OF ETHANOL AND METHADONE IN METHADONE-TOLERANT MICE
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Animals were administered methadone (20 mg/kg/day, p.o.) for seven
previous days. Thirty min. before the eighth dose mice were dosed
with ethanol(2.5 g/kg, p.a.) or water. Each pbint represents the
mean:!:_ SEM of six mice. Brain levels determined by GLC.
* significantly different from control at P <.o5
** significantly different from control at P (.01
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TABLE 14
COMPARISON OF AREAS UNDER GRAPHS OF METHADONE CONCENTRATION
VS TIME AND % MPE VS TIME
Treatment

Figure#

Response

'!:i_

Time

Brain Level vs Time

20 mg/kg, tolerant,
ETOH

22

367

135

20 mg/kg, tolerant,
water

22

(100)

(100)

20 mg/kg, naive,
water

20

343

194

21

320

235

40 mg/kg, tolerant,
water

Areas were integrated from 30 to 150 minutes post methadone and

normalized against the areas under the curves from the 20 mg/kg tolerant

mice administered water.
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concentrations of methadone compared to controls, ethanol was still
able to potentiate methadone in the tolerant state as evidenced by
the much greater increase in antinociceptive response.

Mice tested

at 15 minutes post methadone were retested and sacrificed at 150
minutes.
As shown in figure 23, the half-life of methadone in brain after
a 20 mg/kg oral dose in free-feeding naive mice is 150 minutes.

In

tolerant, free-feeding animals the half-life is decreased to 66 min
utes in control mice but ethanol pretreatment in tolerant mice increased
the half-life to 144 minutes.
Analysis of the serum concentration of ethanol in tolerant mice
(table 15) shows that the initial absorption of ethanol is slightly
decreased compared to naive mice deprived of food.

At later times

the tolerant mice had slightly greater serum concentrations of ethanol.
Comparison of serum concentrations of ethanol in tolerant free-feeding
mice and naive free-feeding mice shows that these alterations are pro
bably due to the presence of food in the stomach rather than to
tolerance to methadone. The ethanol concentration obtained in free
feeding tolerant mice is not significantly different from that obtained
in food-deprived mice.
L) Toxic Effects of Ethanol and Methadone Combinations
Since the antinociceptive properties of methadone were poten
tiated by ethanol, an investigation of the effect of ethanol on the
lethal properties of methadone was undertaken to see if this effect
would also be potentiated. Animals were deprived of food for the 16
hours prior to dosing. The LD50 experiment was started at 4:00 p.m.
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FIGURE 23

v/HOLE BRAIN HALFLIFE OF METHADONE FOLLOWrnG A 20 mg/kg ORAL DOSE
IN NAIVE Arm TOLERENT MICE
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Mice were administered methadone (20 mg/kg/day, p.o.) for seven
previous days. Thirty min. before the eighth dose mice were dosed
with ethanol(2.5 g/kg, p.o) or water. Brain methadone was determined
by GLC. Each point represents the mean_±_ SEM of six mice.
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TABLE 15
ABSORPTION OF ETHANOL IN METHADONE-TOLERENT MICE
WITH FOOD AND lvATER
AD. 1-_lli.
Time After Ethanol
2. 5 g/kg p. 0.
(min)

Serum Ethanol (mg/100 ml ±. SEM)
Naive*

Naive**

Methadone Tolerent

60

222 + 40

90

198 + 21

226

17

203 + 31

120

167 ±. 29

161 + 10

153 + 15

150

140 + 19

155 + 12

162 + 25

174 + 21
.:!:.

*Deprived of food for 16 hours prior to dosing
**With free access to food and water

Figure 24 shows the effect of ora11y administered ethanol on the
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Lo5 0 of ora1ly administered methadone. All animals that died app
eared to die as a result of respiratory depression. No convulsions
were observed. The high doses of methadone emp1oyed increased the
locomotor activity of control mice and seemed to counteract the
initia11y decreased locomotor and exploratory behavior of the ethanol
pretreated mice. Although not initially anticipated, one of the most
significant effects of ethanol in this experiment was an alteration
in the time of death.
Control animals died at an average of 19.7 ±:. 3.5 minutes after
methadone administration. Pretreatment with 2. 5 g/kg ethanol increased
the latency of death to 36.9 ±:. 11.3 minutes. The mice pretreated with
4 g/kg that died within the 6 hour observation period died at an average
of 98 ±:. 17 minutes after dosing. All survivors were al1owed access to
food and water 6 hours after dosing. The only deaths between 6 hours
and 24 hours were several of the animals pretreated with 4 g/kg. Although
included in the calculation of the 24 hour Lo50� these anima1s were
excluded from the calculation of latency of death and brain concentration
of methadone at death.
The 24 hour LD50 of methadone was not significantly alt�red by
pretreatment with 2.5 g/kg ethanol. Pretreatment with 4 g/kg ethanol
did result in a significant decrease in the LD50 of methadone.
Because of the previously demonstrated effects of ethanol on oral
absorption of methadone (figure 12) and the above noted alterations in
latency of death, the Lo50 experiment was repeated using subcutaneous
administration of methadone as shown in figure 25.

In this case, the
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FIGURE 24

THE EFFECT OF ETHANOL ON THE LD50 OF METHADONE (p.a.)
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or water 30 min. prior to administration of methadone. Mice were
observed for 24 hrs. after the dose. There were at least six
mice per group.
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FIGURE 25
THE EFFECT OF ETHANOL ON THE L050 OF METHADONE (s.c.)
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Mice were pretreated with either ethanol (2.5 g/kg, p.o.) or
water 30 minutes prior to administration of methadone. Mice were
observed for 24 hrs. after the dose. There were 10 mice per group.
Control LD50 = 41_mg/kg (33-51)

with 2.5 g/kg ETCH LD50 = 49 mg/kg (44-51)

latency of death was equal in both ethanol and water-pretreated
animals at 14.2 t 7 and 16.3 t 9 minutes respectively.
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As noted

following oral administration, the subcutaneous LD50 of methadone
was also not altered by pretreatment with 2.5 g/kg ethanol.
The brain concentrations of methadone in animals that died during
the course of the LD50 experiments were determined by GLC. As shown

in table 16, animals pretreated with 2.5 g/kg in the oral LD50 experi

ment died at significantly lower brain concentrations of methadone than
controls. Tile animals pretreated with 4.0 g/kg died at even lower brain
concentrations of methadone.
In parallel with the daily administration of methadone at 20 mg/kg/
day to produce tolerance, another group of mice were administered increas

ing oral doses of methadone until they were being maintained on 100 mg/
kg/day.

In these mice. there were no deaths due to the daily dose when

given alone.

However, when these mice were administered either 200 mg/

kg methadone or 2.5 g/kg ethanol combined with the normal daily dose of
100 mg/kg methadone, approximately 30% of each group of mice <lied (table
16).

Analysis of brain methadone in these animals showed that the

animals that died as a result of ethanol and methadone administration
died at slightly lower brain methadone levels than the animals'which died
due to methadone alone.
Prompted by this observation of an approximate twofold increase in
toxicity in animals maintained on high doses of methadone (table 16),
the LD 50 of ethanol in both naive and tolerant mice was investigated

as shown in figure 26 and table 17.
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TABLE 16
BRAIN CONCENTRATIONS OF METHADONE IN METHADDrlE DEATHS
ETHANOL
DOSE
Acute (p.o.)

·--------···-·

Acute (s.c.)

Tolerant a (p.o.)

METHADONE
DOSES

BRAIN METHADONE LEVEL AT
DEATH, µg/g .:1:. SEM

0.0

75-120 mg/kg

4. 9 .:1:. 0.4

2.5

75-120 mg/kg

3.5 + 0.5*

4.0

65-90 mg/kg

l.9 +

0.0

---45-55-- ·------mg/kg

2.5

45-55 mg/kg

0.0

l 00 mg/kg

·------

·-

o. 3

5.5 + 0.5
3.9+0.3*

2.5

l00 mg/kg b

5.1 + 0.7

0.0

200 mg/kg

7.6 + l.2

C

* **

aTolerant animals were administered methadone, 100 mg/kg/day for seven
previous days. This dosing level was attained by first administering
50 mg/kg for one day, then 75 mg/kg for one day and finally 100 mg/kg.
b2.5 g/kg ethanol with 100 mg/kg as the eighth dose killed 9/30 mice
(=30%).

ci�ater with 200 mg/kg as the eighth dose killed 5/18 mice (=28"%).

* significantly different from control at P <.05
*** significantly different from control at P <.005

FIGURE 26
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TABLE 17
LD50 OF ETHANOL IN METHADONE-TOLERANT MICE
LD50 g/kg, p.o.

(95% C.I.)

Naive

8.3

(7.2-9.5)

40 mg/kg/day

7.0

(5.8-8.4)

100 mg/kg/day

2.8*

(2.3-3.4)

Treatment

Mice were not deprived of food and were administered ethanol as
a 25% w/v solution 30 minutes prior to their daily dose of methadone.
There were four groups of six mice/group in each treatment. Mice in
the 40 mg/kg/day group were administered 40 mg/kg/day for ten days.
Mice in the 100 mg/kg/day group were dosed as described in table 16.

*Significantly different from naive mice@ P <.05
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DISCUSSION
A)

Antinociceptive Activity of Ethanol and Methadone
The results of this study demonstrate that a 2.5 g/kg oral dose of

ethanol did not significantly alter the hot-plate response of mice,
although a dose of 4 g/kg interfered with this response. This finding
confirms and extends the early work of Smith and Loomis (144) who found
that the intravenous administration of ethanol at a dose of 1.0 g/kg did
not alter the latency of mice in the hot-plate procedure.
The present study also shows that oral doses of ethanol less than
4.5 g/kg did not significantly alter the tail-flick response of rats.
Administration of a 2.5 g/kg oral dose of ethanol to mice did not alter
their tail-flick response at any time period examined. Increasing the
dose to 4.0 g/kg produced a slight increase in latency, but signifi
cant effects on tail-flick response were not observed until higher doses
were administered. As shown in figure 26, the slope of the Eo50 and
LD50 curves are similar, which suggests the observed alterations in
ta i1-flick latency may be due to general CNS depression.

These results are similar to the results of other tests of antino
ciception, which are also unaffected by low doses of ethanol.

For exam

ple, a 2.0 g/kg oral dose of ethanol did not significantly alter the

.2_-phenylquinone writhing response (65, 143), however the effects of higher
doses 1vere not reported.

Using the toothpulp threshold of rabbits,

Stanton and Keasling (149) showed that intravenous doses of ethanol less
than 3 g/kg did not produce an effect, but increasing the dose of etha
nol produced elevations in threshold which were \>/ell correlated with
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blood-ethanol levels. In contrast.to these results, some test proce

dures such as shock titration procedures in trained rats or electrical
stimulation of the rat tail are altered by intraperitoneal administra

tion of as little as 1.0 g/kg ethanol (22).

The effect of ethanol is similar to that of chloral hydrate and

paraldehyde, which also display antinociceptive properties.at high doses

in the electrical stimulation of the mouse-tail test (112). On the other

hand, barbiturates have been reported· to have either no antinocicepti ve

properties in the rat-tail compression test (52) or to produce increased

sensivity to pain (hyperalgesia) at subanesthetic doses in the hot-plate
(144) and electrical stimulation of the _mouse-tail tests (112).

In this study the effect of ethanol on methadone antinociception

has been studied in a number of different experimental protocols. When

a dose of ethanol not active by itself in the tail-flick test (2.5 g/kg)

was administered prior to (figure 8) or simultaneously with (figure 9)

subcutaneously administered methadone, the antinociceptive response was
greater than methadone treated controls at every time point studied.
The same was true when both drugs were administered by the oral route
(figure 12). This increased antinociceptive effect is not due to an

ethanol�mediated increase in whole brain concentrations of methadone.

In fact, ethanol pretreatment, especially when methadone is also admi

nistered orally, results in significant decreases in the who1 e brain

concentration of methadone when compared to water�pretreated controls.
However, ethanol increased the antinociceptive effect of methadone to

such a degree that in spite of the lower brain concentrations of metha

done, ethanol-pretreated animals displayed a greater antinociceptive
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effect.
To reliably determine the magnitude and significance of the differ
ences between ethanol and water-treated animals, dose-response curves
were established at various times after administration of methadone. A
su11JTiary of the dose-response curves is presented in table 18.

These

results show that a dose of ethanol which by itself is not active in the
tail-flick or hot-plate tests produced a significant increase in the anti
nociceptive effect of methadone in both rats and mice as measured by the
tail-flick test, and also increased methadone antinociception as measured
in the mouse hot-plate test. The potency ratio when mice were adminis
tered ethanol and methadone simultaneously and tested at 60 minutes post
methadone is slightly greater than the potency ratio when mice were ad
ministered ethanol 45 minutes prior to methadone and tested 15 minutes
post methadone.

As can be seen in tables 3 and 6, pretreatment with

ethanol lowered·brain methadone compared to_controls while the brain
concentration of methadone was not decreased relative to controls when
methadone was coadministered with ethanol, which may be responsible for
the difference in the potency ratios.
Due to the ability of ethanol pretreatment to decrease brain con
centrations of methadone, a more useful measure of relative potency may

be obtained from a brain-methadone concentration Y.2- response curve

(figure 7). When examined in this way, it can be seen that ethano 1
increased methadone antinociception to the same degree at 15 minutes
post methadone as it did at 60 minutes post methadone.The calculated whole brain Ec50 of methadone (360 n�/�was approx
imately four times the whole brain EC50 of morphine in the tail-flick
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TABLE 18
SUMMARY OF DOSE-RESPONSE EXPERIMENTS
Testa

Figure#

Potency Rat ;ob

Mouse

HP

4

H20/E,45,M@l5

Mouse

TF

2.0

5

2.sc

Rat

TF

6

2.0

H2D/E and M@60

Mouse

TF

11

2.8

Dosing Protocol

Species

H2 D/E,45,M@l5

Hz0/E,45,M@l5

A dosing protocol where water or ethanol (2.5 g/kg, p.o.) was
administered 45 minutes prior to methadone (s.c.) and animals were
tested 15 minutes later is abbreviated as H2D/E,45,M@15.
aHP = hot-plate test, TF = tail-flick test.

bpotency ratio = control ED50/ED50 in presence of ethanol. In each
case the ED50 1 s are signif1cantTy different at the 95% confidence
1 evel.

Cpretreatment with 4.0 g/kg ethanol gave a potency ratio of 10.
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test (117). Studies of the relative affinity of methadone and morphine
for stereospecific binding sites (119) as well as the relative potency
of both drugs after intraventricular injection (86) indicate that metha
done is intrinisically less effective as an analgesic than morphine.
The observation from this study that greater whole brain concentrations
of methadone are required to produce the same antinociceptive response
as a lesser whole brain concentration of morphine is in agreement with
these studies.
The dose-response curves for methadone in the presence of 0, 2.5
or 4.0 g/kg ethanol (figure 5) clearly show that the effect of ethanol
on methadone antinociception is dependent upon the dose of ethanol,
since the ED50 of methadone in the presence of 4 g/kg ethanol is signi
ficantly different from the ED50 of methadone in the presence of 2.5
g/kg ethanol, which is· significantly different from the control rn50
of methadone.

In addition to being responsive to different doses of ethanol at
a fixed time after ethanol, the increased antinociception also seems
to be responsive to changes in brain ethanol at various times after a
dose of ethanol.

Dose-response curves to methadone were not established

at various times after a single dose of ethanol. However, the results

in figure 13 where ethanol was administered 30 minutes after methadone

show that the amount of methadone in brain is almost constant from 15
minutes post ethanol (i.e. 45 minutes post methadone) to 60 minutes
post ethanol, however, the antinociceptive response increased from 40%
MPE to 100% MPE as brain ethanol levels (from figure 14) rose from 116
to 208 mg/100 g. At 30 minutes post ethanol, the brain concentration
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of ethanol was almost at its peak value, but the antinociceptive re
sponse was only 60% MPE.

At 60 minutes post ethanol, the brain concen

tration of ethanol was slightly greater than at 30 minutes, but the
antinociceptive response increased from 60 to 100% MPE. Thus it seems
that increases in antinociceptive response lagged slightly behind
increases in brain concentrations of ethanol.

The results of adminis

tration of ethanol 90 minutes prior to methadone compared to simulta
neous administration of ethanol and methadone (table 7) suggest that the
decay of the increased antinociception parallels the decline in brain
ethanol.
In addition to experiments in naive mice, the effect of ethanol
on methadone antinociception in methadone-tolerant mice was also ex
amined (figure 22). In this experiment ethanol-treated mice had higher
concentrations of methadone in the brain than controls, although the
observed increase in antinociceptive effect was still greater than would
be expected solely from the increase in brain methadone (table 14).
Since ethanol produced significant alterations in the brain concentra
tion of methadone in both naive and tolerant mice, it was desirable to
compare the degree of potentiation after removing the influence of al
terations in brain concentrations of methadone. This was accomplished

by integrating the areas under the brain-level curve vs. time and the

antinociceptive-response curve�- time. The ratio of antinociceptive
area/brain-level area was called the Effect.

Then the Effect in mice

pretreated with 2.5 g/kg ethanol was divided by the Effect in mice pre
treated with water.
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Effect

Naive, s.c.
(figure 8)

Naive, p.o.
(figure 12)

ETOH

Tolerant, p.o.
(figure 22)

2.7
2.5
2.7
H20
Thus, when corrected for differences in brain level, ethanol increased
Effect

the antinociceptive effect of methadone to a similar extent in both
naive and tolerant mice.
The antinociceptive effect of ethan61 and methadone combinations
is greater than would be expected from simple addition of the observed
antinociceptive effects of each drug given alone.

For example, the ED 50

of methadone at 15 minutes is 2.0 mg/kg (figure 5). Addition of the

observed effect of 4.0 g/kg ethanol when administered alone (13% MPE,
table 2) would result in a decrease in the Eo50 of methadone to 1.4
mg/kg. However, the ED50 of methadone in mice pretreated with 4.0 g/kg

ethanol is 0.2 mg/kg. Similar observations can be made based on the ob-

served results in the other dose-response curves as well as the various
time-course experiments. Since the combination of ethanol and metha
done produced an antinociceptive effect greater than the sum of the
effects of ethanol and methadone administered individually, it is appropriate to classify the interaction of these two agents as Gne of po
tentiation. This potentiation could be the result of a number of factors.
Just as there are doses of methadone that would produce a degree
of antinociception below the sensitivity of the tail-flick, there are
doses of ethanol which would also produce a degree of antinociception
not detectable with the tail-flick. In view of the activity of doses
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of ethanol as low as 1.0 g/kg in some antinociceptive tests such as
electrical stimulation of the tail (22), it is possible that 4.0 or even
2.5 g/kg ethanol exerts an antinociceptive effect which is below the
sensitivity of the tail-flick, but when combined with methadone, becomes evident as a shift of the methadone dose-response curve to the left.
It is impossible to verify the existence of, let alone measure, this
subthreshold effect in the tail-flick by its very definition. However,
it is possible to estimate its maximum magnitude in order to see if the
potentiation of ethanol and methadone antinociception could be due to
addition of a subthreshold effect of ethanol to the expected antinoci
ceptive response of methadone.
If there is a subthreshold effect then it is implied that zero
activity in the tail-flick test is above zero antinociception. The
question then becomes; how far are they separated? If the observed
effect of 4.0 g/kg ethanol (13% MPE) is just at, or even slightly above,
the tail-flick threshold, then it is possible to answer this question
by determination of the amount of methadone required to equal this re

sponse.
Since unclosed animals would not display any methadone antinoci

ception, that is O ng/g = zero antinociception, and from figure 7, 13%
MPE would be produced in control animals by a dose of methadone which
yielded a brain concentration of methadone of 130 ng/g, the maximum
magnitude of the difference in brain-methadone concentration between
zero antinociception and the tail-flick threshold is approximately
Thus, if the decrease in the Ec50 in ethanol-treated mice
was due to a subthreshold effect of ethanol the maximum it could be
130 ng/g.
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Comparison of the contro1 EC50 after sub
traction of this maximum possib1e subthreshold effect with the Ec5 of
0
methadone in mice pretreated with 4.0 g/kg ethano1 reveals that there
decreased by is 130 ng/g.

is sti11 a significant difference between the two groups. This indi
cates that ethanol has an effect greater than could be produced by simple
addition ·of a possib1e subthreshold effect of ethanol to the antino
ciceptive properties of methadone.
The findings that ethanol treated animals disp1ay a greater anti
nociceptive response than controls at the same or even lower whole
brain concentrations of methadone, and that this increased response is
not due to addition of subthreshold antinociceptive effects of ethanol
suggests that the observed potentiation is the result of an ethanol
mediated increase in the apparent CNS sensitivity to methadone.

This

apparent increase in sensitivity may be due to a number of factors.
Ethano1 may increase the effective concentration of methadone at
the opiate receptor without necessarily altering the antinociceptive
response produced by methadone's interaction with the receptor. Since
the distribution of stereospecific opiate binding is not uniform
throughout the CNS (85) and it has been shown that the distribution of
methadone is not uniform within the brain (122), it is possible that
ethanol alters the distribution of methadone within the brain and in
creases the amount of methadone at these receptors without altering
who1e brain 1evels.

As opiate binding is predominantly associated with

the membrane fraction of brain (120) and ethano1 has been shown to in
crease the f1uidity of synaptosomal membranes from the brain (29), it
is possible ethanol may enhance the availability of the opiate receptor
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for interaction with methadone.
Since the pKa of all narcotics is above 7.4, the active form of
narcotics is thought to be protonated (25). Recent quantum chemical
studies of methadone confirm earlier findings that the lowest energy
form of protonated methadone is a folded configuration with a hydrogen
bond-r.ike interaction of the carbonyl oxygen with the protonated amine
to form a pseudopiperidine ring.

However, this most stable configura

tion does not overlap very well with the structure of morphine.

A more

morphine-like structure, and one which would presumably have a ·higher
affinity for the opiate receptor is an extended chain configuration (95).
Since ethanol possesses both good hydrogen bonding capabilities and lip
id solubility, it is possible ethanol could favor the formation of this
more active conformation of methadone at the receptor and thereby in
crease the activity of methadone.
Increased levels of calcium have been shown to decrease stereo
specific binding of opiates � vitro (121).

In agreement with this

finding, intraventricular calcium decreases and intraventricular EGTA
increases the potency of morphine (63). The demonstration that ethanol
produces a rapid and dose-related decrease in brain concentrations of
calcium (131, 132) suggests that ethanol may potentiate methadone anti

nociception by depletion of regional brain calcium.

Finally, as recently reviewed by Takemori (156) increases in the
turn-over or concentration of various neurotransmitters such as serotonin, acetylcholine and dopamine have been shown to increase opiate
antinociception.

Although the results of different studies of the

effects of ethanol on these neurotransmitters are far from uniform (78),
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owing in part to different doses of ethanol, different species and dif
ferent methods of analysis, ethanol has been shown to produce increased
whole brain levels of all three neurotransmitters in female ICR mice (49).
Thus, it is possible that the ethanol potentiation of methadone anti
nociception observed in the present study is mediated by alterations
in one or all of these neurotransmitters.
Although none of the above mentioned mechanisms for an ethanol
mediated increase in the CNS sensitivity to methadone antinociception
have been specifically investigated in the present study, the data
presented are consistent with this hypothesis.

The fact that ethanol

produces a parallel shift in the dose-response curves to methadone sug
gests that methadone is exerting its antinociceptive effect through
the same type of receptors in both control and ethanol-treated mice.
In addition, as shown·in figure 17, increasing doses of naloxone pro
duced equal antagonism of both methadone, and ethanol-methadone antino
ciception which provides a preliminary indication that ethanol did not
alter the naloxone-receptor interaction which in turn implies that
ethanol did not alter the configuration of the receptor. However, to
validate this it would be necessary to determine the apparent pA2 of
naloxone (147) in both ethanol and water-treated mice.
Further support for the hypothesis that the potentiation between
ethanol and methadone is due to a change in CNS sensitivity is provided
by consideration of some other possible mechanisms of increased antino
ciception.

For example, tetrahydropapaveroline alkaloids or salsolinol

have not been demonstrated i!1_ vivo after a single dose of ethanol with
out prior treatment with dopa (161).

However, since methadone blocks
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dopamine receptors (137) and causes an increase in central dopamine syn
thesis (19), the formation of these alkaloids may be favored when etha
nol and methadone are coadministered.

Evidence of antinociceptive ac

tivity of both 3-carboxysalsolinol (102) and a derivative of tetrahydro
papaveroline (136) supports the possibility that some of the increased
antinociception of ethanol and methadone combinations is due to the for
mation of these alkaloids.

However, since the observed potentiation

is dependent upon the dose of ethanol and the brain level of acetalde
hyde would be the same at different brain concentrations of ethanol
(155), these condensation products are probably not involved in the po
tentiation.
Since high brain concentrations of ethanol increase tail-flick
latency, it is possible that the increase in antinociception produced
by combinations of ethanol and methadone is due to a methadone-mediated
increase in ethanol levels.

However, as shown in tables 2 and 10, for

subcutaneously administered methadone and in figure 14 for orally admi
nistered methadone, methadone does not significantly increase whole
brain concentrations of ethanol under conditions where ethanol and metha
done produce greater antinociception than methadone alone.
Increased production of active metabolites of cl-methadone under
the influence of ethanol could also explain the increased activity of
ethanol and methadone combinations, but as shown in figure 16, ethanol
also potentiates }_-methadone, which has no known metabolites with anti
nociceptive activity (152).
Thus, when all the data are considered, the most reasonable expla
nation of the ethanol potentiation of methadone antinociception is an
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ethanol-mediated change in the CNS sensitivity to methadone's antinociceptive properties.
B)

Effect of Ethanol on Brain Concentration of Methadone and Effect of
Methadone on Brain Concentration of Ethanol
The present study has investigated the absorption and distribu

tion of methadone in mice and the ability of ethanol to alter these
processes, especially as they are reflected in alterations of brain con
centrations of methadone.

It was found that the brain to serum ratio of

methadone in control mice at both a constant time after subcutaneous
administration of various doses of methadone (tables 3 and 6) as well
as at various times after a single dose of methadone (table 4) was very
close to unity. These data are in agreement with the results of a
recent study of methadone distribution in mice (141) and contrast with
the generally higher brain to serum ratio of methadone found in rats
(94, 108).
Pretreatment of mice with 2.5 g/kg ethanol produced brain concentrations of methadone consistently lower than control mice when exam
ined 15 minutes after subcutaneous administration of methadone (table
3).

Ethanol pretreatment did not alter the brain/serum ratio of metha

done since the lesser brain concentrations of methadone were paralleled
by lesser serum concentrations of methadone.

When the concentrations

of methadone in liver, lung, brain and serum were examined at various
times after a subcutaneous dose of methadone (table 4) it was again
found that ethanol_ pretreatment decreased brain and serum methadone at
every time point studied.

In addition, as shown in table 5, ethanol
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pretreatment also produced significant increases in the liver/serum and
lung/serum ratios of methadone concentration.

The decline in brain and

serum methadone can not be explained by decreased absorption since it
was found that the absorption of methadone from the subcutaneous injec
tion site was both rapid and unaffected by ethanol pretreatment.
The magnitude of the decrease in brain concentration of methadone
was the same after pretreatment with either 2.5 g/kg or 4.0 g/kg etha
nol.

This raised the possibility that the decreased brain level was

caused by acetaldehyde.

Mccloy et.!}_. (96) have shown, for example,

that intra-arterial injection of acetaldehyde dilates vascular beds in
the hepatic artery, while constricting those in the carotid and femoral
arteries.

In addition, intravenous ethanol has been shown to increase

heart rate, systemic arterial pressure and myocardial contractile force
in dogs (llO).

\•Jhil e ·these effects may be responsible for increases

in peripheral tissue levels of methadone which could contribute to de
creases in brain and serum concentrations of methadone, the observed
redistribution of methadone may not be the only factor involved.
As shown in figures 9 and 10 and table 6, when ethanol was admin
istered after, or even simultaneously with the subcutaneous administra
tion of methadone, the brain concentrations of methadone in both etha
nol-treated and control mice were generally equal. This study has shown
that ethanol is rapidly absorbed after oral administration to mice de
proved of food as evidenced by a brain concentration of ethanol of 159
mg/100 g 15 minutes post-administration.

Since ethanol metabolism

would immediately produce acetaldehyde, if ethanol-mediated redistribu
tion of methadone was the underlying cause of alterations in brain and
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serum methadone, these alterations would be expected to be similar whether
ethanol was administered simultaneously with, or administered prior to,
methadone.
While the response to acetaldehyde is immediate, other effects of
ethanol are more delayed.

For example, ethanol produces a marked diu

retic response due to its ability to suppress antidiuretic hormone re
lease (162).

However, the diuresis is short lived and is followed by

a period of decreased urine formation (106).

Thus, pretreatment with

ethanol may produce a diuretic response at the same time methadone is
being rapidly absorbed and serum concentrations of methadone are high and
thereby increase the initial excretion of methadone. The effect of etha
nol on excretion may be magnified since methadone decreases urine for
mation (72) and control mice may be producing a lower than normal urine
volume at the same time ethanol-treated mice are producing a greater
than normal urine flow.

When ethanol and methadone are administered

simultaneously, the diuretic effect may only develop after serum con
centrations of methadone are much lower and therefore the increased
urine volume is less effective in producing noticeable changes in brain
and serum concentrations of methadone. The fact that the effects of
2.5 and 4.0 g/kg ethanol are similar may indicate that 2.5 g/kg maxi
mally inhibits antidiuretic hormone release (34).

Further study of the

effects of ethanol and methadone combinations on urine formation and
the excretion of methadone are needed to clarify the role of excretion
in the observed decrease of brain concentrations of methadone.
When ethanol and methadone are administered orally, initial brain
concentrations of methadone are approximately 40% less than in control
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mice (figure 12).

This decrease is probably due to the same effects

noted following subcutaneous administration as well as an additional
effect of ethanol to initially decrease absorption of methadone from the
gastrointestinal tract. As shown in table 8, both 2.4 and 4.0 g/kg
ethanol delay the loss of methadone from the stomach to a similar ex
tent. Studies of the oral absorption of methadone in rats with or with
out a pyloric ligation show that although some methadone is absorbed
from the stomach, the greater portion is absorbed from the small intes
tine which makes gastric emptying the rate-limiting step in the oral ab
sorption of methadone (170). Since ethanol is known to inhibit gastric
emptying when administered by either the oral (8) or intravenous (59)
route but does not alter absorption of methadone once methadone is in
the duodenum (170), the ethanol-mediated initial decrease in gastroin
testinal absorption of· methadone is evidently produced by delayed entry
of methadone into the small intestine. Thus ethanol, by decreasing
gastric emptying prevents the rapid absorption of methadone seen in
controls and produces a more gradual and sustained absorption of metha
�one which results in brain concentrations of methadone initially lower
and finally greater than controls. As can be seen in figure 12, both
4.0 and 2.5 g/kg ethanol produced the same effects on brain concentra
tion of methadone. This is probably due to the use of the same concentra
tion of ethanol to dose both groups and as mentioned above, both doses
produce similar effects on the distribution and excretion of methadone
once it is absorbed.
As shown in figure 15, the half-life of methadone in the brain
after subcutaneous administration was not altered by pretreatment with
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2.5 g/kg ethanol.

When considered in conjunction with the lack of effect

of ethanol treatment on the relative amounts of methadone, EDDP, and
EMDP excreted in bile and urine, these observations suggest that this
dose of ethanol does not significantly alter .ill. vivo metabolism of metha
done. Surplementary information on the effect of ethanol on methadone
metabolism .ill. vitro is lacking although Cohen and Mannering (35) found
ethanol did not alter N-demethylation of methadone at concentrations
which decreased aniline para-hydroxylation.

However, since ethanol is

a more potent inhibitor of the metabolism of type II compounds (ani
line) than of type I compounds (methadone) and they did not investigate
higher concentrations of ethanol, their investigation does not neces
sarily support the concept that ethanol does not alter methadone meta
bolism in vivo.
It is possible that the lack of effect of ethanol on the half-life
of methadone in brain reflects an ethanol-mediated inhibition of metha
done metabolism which is masked in the whole animal by other effects of
ethanol.

For example, the observed increased concentration of metha

done in the liver of ethanol-treated mice may compensate for an ethanol
mediated inhibition of methadone metabolism.

In mice maintained on an

oral dose of methadone of 20 mg/kg/day, the oral administration of etha
nol (2.5 g/kg) prior to the last dose produced an increase in the half1 ife of methadone in brain compared to controls (figure 23). However,
this alteration in half-life may not be due to an ethanol inhibition of
methadone metabolism but due to an initial delay in methadone absorption
as was shown in naive mice deprived of food.

To circumvent this pos

sibility, it would be useful to study the effects of ethanol in mice
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made tolerant to methadone by subcutaneous administration.
tion, further work on the

j__Q.

In addi

vitro metabolism of methadone in both naive

and methadone-tolerant mice is needed to clarify the effects of ethanol
on methadone metabolism.
In contrast to the significant effects of ethanol on brain concen
trations of methadone, especially when both drugs are administered
orally, methadone generally produced only slight alterations in brain
concentrations of ethanol.

In fact, as shown in figure 14, the only

significant change produced by a 30 minute oral pretreatment with metha
done was a lower brain concentration of ethanol 15 minutes post ethanol.
There is also some indication of a delay in the time of peak concen
trations of ethanol, however, the rate of decline in brain concentra
tions of ethanol is little affected by methadone.

As shown in tables

2 and 10, subcutaneous administration of methadone also has little ef
fect on the brain concentrations of ethanol.

The alterations observed

are probably a reflection of the anticholinergic properties of metha
done (171) which would delay gastric emptying in agreement with the
effects of other drugs with anticholinergic properties on ethanol ab
sorption (41, 54, 60).

Since ethanol is well absorbed from the stomach

even when the stomach is ligated at the pylorus (79), it is to be ex

pected that alterations in the rate of gastric emptying have a greater
effect on methadone absorption than on ethanol absorption.
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C)

Toxicity of Ethanol and Methadone Combinations
In view of the common CNS depressant properties of ethanol and

methadone, it would not be surprising to find an increase in the toxi
city of methadone when combined with ethanol.

However, as shown in fig

ure 24, pretreatment with ethanol did not significantly alter the ob
served LD50 of orally administered methadone until an ethanol dose of
4.0 g/kg was employed. It would seem likely that ethanol would alter
the absorption of lethal doses of methadone in a fashion similar to
pharmacological doses, and therefore insight into the effects of ethanol
on the LD50 of methadone could be gained by referring to the effects
of ethanol pretreatment upon brain concentrations of methadone shovm in
figure 12.

Control animals rapidly achieved high brain concentrations

of methadone, while ethanol pretreatment suppressed this initial rapid
absorption and produced a more gradual increase in brain concentra
tions of methadone. Thus, even at the same dose of methadone, the maxi
mum brain concentration of methadone achieved by ethanol-pretreated mice
is much lower than the maximum achieved by controls.

Due to these etha

nol-mediated alterations in brain concentration of methadone, the in

creased toxicity of ethanol and methadone combinations is see� not as
a shift in the LD50, but as a significantly lower concentration of metha
done in the brain at death as shown in table 16.
The ability of ethanol to alter brain concentration of methadone
may also be partly responsible for the observed increased latency of
death in ethanol-pretreated mice.

Since ethanol delays the increase in

brain concentration of methadone, ethanol-pretreated mice require a
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longer time to achieve a lethal concentration of methadone even though
this concentration is less than in control mice. Since the effects
of 4.0 and 2.5 g/kg ethanol on the time course of brain concentration
of methadone are similar, but the latency of death in mice pretreated
with 4.0 g/kg is significantly greater than when mice are pretreated
with 2.5 g/kg, ethanol may increase the latency of death by other mecha
nisms in addition to initially decreasing brain concentrations of metha
done.

For example, in addition to CNS depression, methadone dispiays

some CNS stimulant properties in mice as evidenced by its ability to
increase locomotor activity (figure 19).

During the Lo50 experiment,

it was observed that ethanol-pretreated mice did not seem to exhibit

as much locomotor activity as control mice. Thus, ethanol may have in
creased the latency of death by initially protecting the mice from the
stimulant properties of methadone.
Since mice pretreated with 2.5 g/kg ethanol did survive slightly
longer than controls, the decreased brain concentration of methadone at
death may not necessarily reflect an initial delay in methadone delivery
to the brain, but could be due to the longer time the animal was alive
and metabolizing methadone. To evaluate this possibility methadone was
administered subcutaneously. Under these conditions both ethanol-treated
and control mice died at approximately the s,me time. As shown in table
16, the brain concentrations of methadone in the mice that died in the
ethanol pretreated group was still significantly lower than in the con
trols.
These experiments indicate that it took a lower brain concentra
tion of methadone to be lethal in mice pretreated with ethanol, but
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since ethanol also decreased the percent of the dose which reached the
brain, the Lo50 was not altered until higher doses of ethanol were em
ployed. Thus, although 2.5 g/kg ethanol increased the antinociceptive
response to such an extent that the dose-response curve was shifted to
the left in spite of a lower brain concentration of methadone, this same
dose of ethanol did not increase the toxic effects of methadone enough
to overcome the decrease in brain concentration.
It was observed that combination of a 2.5 g/kg dose of ethanol with
the daily dose of methadone in mice maintained on 100 mg/kg/day produced
as many deaths as were produced by doubling the daily dose of methadone.
Further investigation of the Lo50 of ethanol in methadone tolerant mice
(table 17) revealed that, as might be expected, the higher the mainte
nance dose of methadone, the lower the LD50 of ethanol. These findings
may parallel the methadone maintenance patient who combines ethanol and
his daily methadone dose and succumbs to their combined effect when the
daily dose of methadone alone would have been tolerated.
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SUMMARY

Ethanol causes a significant potentiation of the antinociceptive
properties of methadone in both naive and methadone-tolerant mice as
measured in the tail-flick procedure.

This increased antinociception

is not due to an ethanol-mediated increase in whole brain concentration
of methadone.

Ethanol pretreatment was found to cause a significant

decline in whole brain concentrations of methadone. It is hypothesized
that the increased antinociceptive response to combinations of ethanol
and methadone is the result of an ethanol-mediated increase in central
nervous system sensitivity to methadone.
Ethanol treatment does not alter the half-life of methadone in the
brain, nor does it alter the relative amounts of methadone and its major
nonconjugated metabolites excreted in the bile or urine of naive mice.
Ethanol pretreated mice die at a lower brain concentration of metha
done than mice that die as a result of methadone alone.

However, since

ethanol also alters the percent of the methadone dose which reaches the
brain, the LD50 of methadone is not altered by pretreatment with an
ethanol dose of 2.5 g/kg. In mice maintained on high daily doses of
methadone, there is a decline in the LD50 of ethanol.

126
REFERENCES

1. Agar, M. and Stephens, R. The methadone street scene: The
addicts view. Psychiatry, 38: 381-387 (1975).
2. Aggarwal, V. and Bath, R. Analytical method for lidocaine. In
Methodology for Analytical Toxicology, Sunshine, I., ed., pp 213214. CRC Press, Cleveland, 1975.
3. Alvares, A. and Kappas, A. Influence of phenobarbital on the
metabolism and analgesic effect of methadone in rats. J. Lab.
and Clin. Med., .z2.: 439-451 (1972).
4. AMA Council on Mental Kealth. Oral methadone maintenance tech
niques in the management of morphine type dependence. J. Amer.
Med. Assoc.,�: 1618-1619 (1972).
5.

Anggard, E., Gunne, L., Kolmstrand, J., McMahon, R., Sandbers,
C., and Sullivan, H. Disposition of methadone in methadone
maintenance. Clin. Pharmacol. Therap., lZ_: 258-256 (1974).

6. Archer, S., Karris, L., Albertson, N., Tullar, B., and Pierson,
A. Narcotic antagonists as analgesics. In Advances in Chemistry
Series, #45, Schueler, F., ed., pp 162-169. American�em1cal
Society, Washington, D.C., 1964.
7. Arky, R. Carbohydrate metabolism in alcoholics. In Tbe Biology
of Alcoholism, Kissin, B. and Begleiter, H., eds., vol 1. pp 211-·
216. Plenum Press, New York, 1971.
8 . Barboriak, J. and Meade, R. Impairment of gastrointestinal
processing of fat and protein by ethanol in rats. J. Nutr., 98:
373-378 (1969).
9. Baselt, R. and Bickel, M. Biliary excretion of methadone by the
rat: Identification of a para-hydroxylated major metabolite.
Biochem. Pharmacol., �: 3117-3120 (1973).
10. Baselt, R. and Casarett, L. Biliary and urinary elimination of
methadone and its metabolites in the rat. Biochem. Pharmacol.,
24: 2705-2712 (1972).
11.

Bass, W. and Vanderbrook, M. A note on an improved method of
analgetic evaluation. J. Amer. Pharm. Assoc., :!l_: 569-570
(1952).

127
12. Bastos,M. Methadone deaths in New York City. Presented to the
annual meeting of the Society of Forensic Toxicologists, Toronto,
(1974).
13. Bastos,M. and Galante, L. Toxicological findings in victims of
traumatic deaths. J. For. Sci.,£l.: 176-186 (1976).
14. Bath, R. Personel communication, W estchester County, New York,
(1976).
15. Beckett,A.,Mitchard, M., and Shihab,A. The influence of
methyl substitution on the N-demethylation and N-oxidation of
nor-methadone in animal species. J. Pharm. Pharmacol.,23: 941946 (1971).
16. Beckett,A., Mitchard,M.,and Shihab, A. Identification and
quantitative determination of some metabolites of methadone,
isomethadone and normethadone� J. Pharm. Pharmacol.,23:
- 347352 (1971).
17. Beckett,A., Vaughan, D.,and Essien, E. N-oxidation- An import
ant route in the metabolism of methadone in man. J. Pharm.
Pharmacol. ,24: 244 (1972).
18. Bihari, B. Alcoholism and methadone maintenance. Amer J. Drug
and Alcohol Abuse, l: 79-87 (1974).
19. Bloom,A., Dewey, W., Harris, L., and Brosius, K. The correl
ation between antinociceptive activity of narcotics and their
antagonists as measured in the mouse tail-flick test and in
creased synthesis of brain catecholamines. J. Pharmacol. Exp.
Ther.,�: 33-41 (1976).
20. Blum, K., Futterman,S.,Wallace,J., and Schwertner, H. Nal
oxone induced inhibition of ethanol dependence in mice. Nature,
265: 49-51 (1977).
21. Blum, K., Wallace,J., Schwertner, H. Morphine suppression of
ethanol withdrawal in mice. Experentia, R: 79-82 (197.6).
22. Brick, J., Sun, J., Davis, L.,and Pohorec;:ky, L. Ethanol and the
response to electric shock in rats. Life Sciences, 1:§_: 12931298 (1976).
23. Caplan,Y. Personel communication, Office of the Chief Medical
Examiner,Baltimore,Maryland, (1977).
24. Carpenter,J.,Marshman,J., Gibbins, R. Drug Interactions: The
effects of alcohol and meprobamate applied singly and jointly in
human subjects. J. Studies Ale.,?.... (Suppl) (1975).

128
25. Casy, A. Analgesic Receptors. In Modern Pharmacoloqy: A Guide
To Molecular Pharmacology-Toxicology, Featherstone, R., ed.�
1, part 1, pp 217-278. Marcel Dekker, New York, 1973.
26. Chabalko, J., LaRosa, J., and Dupont, R. Death of methadone
users in the District of Columbia. Int. J. Addict., t: 897-908
(1973).

27. Charuvastra, L., Panell, J., Hopper, M., Erkmann, M., Blakis, M.,
and Ling, l�. The medical safety of the combined usage of disulf
iram and methadone. Arch. Gen. Psy., ll._: 391-393 (1976).
28. Chen, K. Pharmacology of methadone and related compounds. Ann.
N. Y.Acad.Sci.,�: 83-97 (1948).
29. Chin, J. and Goldstein, D. Drug tolerance in biomembranes: A
spin 1 abel study of the effects of ethanol. Science, 112_: 684685 (1976).
30. Chung, H. and Brown, D. Mechanism of the effect of acute ethanol
on hexobarbital metabolism. Biochem. Pharrnacol., 25: 1613-1616
(1976).
31. Chung, H. and Brown, D. Alcohol-hexobarbital interaction in rats
under acute stress. LifeSciences, 1.§_: 123-128 (1976).
32. Cinti, D. The effect of ethanol on drug oxidations in vitro and
the significance of ethanol-cytochrome P-450 interactio�
Biochern. J., fil: 367-375 (1973).
33. Clark, E. Isolation and Ictentification --of Drugs, p 801. The
Pharmaceutical Press,London, 1969.
34. Cobo, E. and Quintero, C. Milk ejectin� and antidiuretic act
ivities under neurohypophyseal inhibition with alcohol and water
load. Arner. J. Obst. Gynec., 105: 877-887 (1969).
35. Cohen, G. and Mannering, G. Involvement of a hydrophobic site in
the inhibition of the microsomal E_-hydroxylation of aniline by
alcohols. Mol. Pharmacol., �: 383-397 (1973).
36. Coldwell, B., Paul, C., and Thomas, B. Phenobarbital metabolism
in ethanol intoxicated rats. Can. J. Physiol. Pharmacol., 51:
458-463 (1973).
37. Coldwell, B., Trenholm, L.·. Thomas, B., and Charbonneau, S. The
effect of ethanol on phenobarbital and pentobarbital absorption
into rat blood and brain. J. Pharm. Pharmacol. 23: 947-949
(1971).

129
38. Collins, M. and Bigdeli, M. Tetrahydroisoquinolines .1_.!!_ vivo I.
Rat brain formation of salsolinol, a condensation produtt of
dopamine and acetaldehyde, under certain conditions during
ethanol intoxication. Life Sciences, Q_: 585-602 (1975).
39. Conover, W. Practical Nonparametric Statistics, p 224. Wiley
and Sons, New York, 1971.
40. Crone, C. The permeability of brain capillaries to non-elect
rolytes. Acta Physiol. Scand., 64: 407-417 (1965).
41. Cudworth, A., Barber, H., and Calvey, T. The effect of codeine
phosphate on the absorption of ethyl alcohol. Brit. J. Clin.
Pharmacol., 2: 65-67 (1975).
42. D'Amour, F. and Smith, D. A method for determining loss of pain
sensation. J. Pharmacol. Exp. Ther., ?J...: 74-79 (1941).
43. Davis, V. and Walsh, M. Alcohol, amines, and alkaloids: A
possible biochemical basis for alcohol addiction. Science, 167:
1005-1007 (1970).
44. Dole, V. and Nyswander, M. A medical treatment for diacetyl
morphine (heroin) addiction. J. Amer. Med. Assoc.,�: 80-84
(1965).
45 Dole, V. and Nyswander, M. Methadone maintenance treatment- A
ten year perspective. J. Amer. Med. Assoc.,�: 2117-2119
(1976).
46. Eddy, N. and Leimbach, D. Synthetic analgesics II; Diethienyl
butanyl and diethienylbutylamines. J. Pharmacol. Exp. Ther.,
107: 385-393 (1953).
47. Eerola, R. The effect of ethanol on the toxicity of hexobarb
ital, thiopental, morphine, atropine, and scopolamine. An exper
imental study on mice. Ann. Med. Exptl. Biol. Fenniae, Helsenki,
39: Suppl. 3, 1-70 (1961).
48. Eerola, R. The effect of ethanol on the toxicity of promazine,
chlorpromazine, promethazine, and hydroxyzine. Acta Anaesth.
Scand., Z_: 87-95 (1963).
49. Erickson, C. and Matchett, J. Correlation of brain amine changes
with ethanol induced sleep-time in mice. Adv. Exp. Med. Biol.,
59: 419-430 (1975).
50. Forney, R. and Hughes, F.

Combined Effects ------of Alcohol and Other

Drugs. Thomas, Springfield, Ill., 1968.

51 Freedman, L. Methadone and Alcohol. Ann. N. Y. Acad. Sci. 273:
624-628 (1976).

130
5 2. Geller, E., Durlofsky, L., Harakal, C., Cowan, A. and Adler, M.
Pentobarbital does not influence the antinociceptive effects of
morphine in naive or morphine tolerent rats. Pharmacologist, 19:
83 (1977).
53. Gessner, P. and Cabana, B. A study of the interaction of the
hypnotic effects and of the toxic effects of chloral hydrate and
ethanol. J. Pharmacol. Exp. Ther., 174: 247-259 (1970).
54. Gibbons, D. and Lant, A. Effects of intravenous and oral propan
theline and methorlopramine on ethanol absorbtion .. Clin. Pharm
acol. Ther., lZ_: 578-584 (1975),
55. Ginzberg, H. Substance substitution: Do methadone maintenance
patients become alcoholics? In Currents in Alcoholism, Seixas,
F., ed., vol II, pp 25 3-267. Grune and Stratton, New York, 1977.
56 . Goldstein, A. Blind controlled dosage comparisons with methadone
in 200 patients. In Proceedings of the Third National Conference
on Methadone Treatment, pp 31-37.----PuETic Health Service Publica
tion No. 2172, U.S. Government Printing Office, 1972.
57. Goldstein, A. The status of methadone maintenance. Reported to
the 37th meeting, Committee on Problems of Drug Dependence, Wash
ington, D.C., National Research Council, National Academy of
Sciences, pp 39-49, 1975.
58. Goldstein, A. and Judson, B. Efficacy and side effects of three
widely different methadone doses. In Proceedings of the Fifth
National Conference on Methadone Treatment, pp 21-40.---Wational
Association for the Prevention of Addiction to Narcotics, New
York, 1973.
59. Greenberg, L., Lolli, G., and Rubin, M. The influence of intra
venously administered alcohol on the emptying time of the stomach
Quart. J. Stud. Ale.,�: 371-375 (1942).
60. Hall, R., Brown, D., Carter, R., and Kendall, M. The effect of
desmethylimipraminP on the absorption of alcohol and paracetamol.
Postgrad. Med. J., §_g_: 139-142 (1976).

61. Hamilton, M., Hirst, M., and Blum, K. Central formation of an
abnormal amine metabolite after chronic exposure to ethanol.
Pharmacologist, 12._: 138 (1977).

62. Hamilton, M., Marshall, A., Blum, K., and Hirst, M. Effect of
salsolinol on the field - stimulated guinea pig ileum. Pharma
cologist, 18: 102 (1976).

131
63. Harris, R., Loh, H., and Hay, E. Effects of divalent cations,
cation chelators and an ionophore on morphine analgesia and toler
ance. J. Pharrnacol. Exp. Ther., 195: 488-498 (1975).
64. Heikkila, R., Cohen, G., and Pernbies, D. TetrahyQroisoquinoline
alkaloids: uptake by rat brain homogenates and inhibition of cate
cholamine uptake. J. Pharmacol. Exp. Tiler., 1:22_: 250-258 (71).
65. Hendershot, L. and Forsaith, J. Antagonism of the frequency of
phenylquinone-induced writhing in the mouse by weak analgesics and
nonanalgesics. J. Pharmacol. Exp. Ther., �: 237-240 (1959).
66. Henkel, J., Bell, K., and Portoghese, P. Stereochemical studies
on medicinal agent 16. Conformational studies of methadone and
isomethadone utilizing circular dichroism and proton magnetic
resonance. J. Med. Chern., lZ_: 124-129 (74).
67.

Hetland, L. and Couri, D. Effects of ethanol on glutethirnide ab
sorption and distribution in relationship to a mechanism for toxi
city enhancement. Taxicol. Appl. Pharmacol.,lQ_: 26-35 (74).

68. Ho, A., Chen, R., and Morrison, J. · Narcotics, narcotic antago
nists, and ethanol during acute, chronic, and withdrawal states.
Ann. N.Y. Acad. Sci., 281: 297-310 (76).
69.

Ho, I. and Berndt, \'1. Effect of chronic administration of pento
barbital on methadone analgesia and toxicity. Life Sciences,�:
1305-1314 (76).

70. Horns, H., Rado, M., and Goldstein, A. Plasma levels and symptom
complaints in patients maintained on daily dosage of methadone
hydrochloride. Clin. Pharrnacol. Ther., lZ_: 636-649 (75).
71. International Critical Tables, Hashburn, E., ed., vol. 5 (New York:
McGraw-Hill, 1930), p. �
72. Inturrisi, C. and Fujimoto, J. The antidiuretic effect of narcotic
analgesics in the mouse. Toxicol. Appl. Pharrnacol., l?_: • 251-157
(1968).

73. Inturrisi, C. and Verebely, K. A gas-liquid chromatographic method
for the quantitative determination of methadone in human plasma
and urine. J. Chrorn., �: 361-369 (1972).
74. Isbel, H., Hilker, A., Eisenman, A,, Daingerfield, M., and Frank,
K. Liability of addiction to 6-dimethylarnino-4,4-diphenyl-3-hepta
none in man. Arch. Intern. Med., 82: 362-392 (1948).
· 75. Israel, Y., Carmichael, F., and MacDonald, J. Effects of ethanol
on electrolyte metabolism and neurotransmitter release in the CNS.
Adv. Exp. Med. Biol., �: 55-64 (1975).

132
76. Iverson, F., Coldwell, B., Downie, R., and Whitehouse, L. Effect
of ethanol on toxicity and metabolism of amphetamine in the mouse.
Experientia, ll:..: 679-680 (1975).
77. Kalant, H. Absorption, diffusion, distribution and elimination of
ethanol. In The Biology of Alcoholism, Kissin, B. and Begleiter,
H., eds., vol. 1. pp. 1 -=-6"°5. Plenum Press, New Yori<, 1971.
78. Kalant, H. Direct effects of ethanol on the nervous system. Fed.
Proc., 34: 1930-1941 (1975).
79. Karel, L. and Fleisher, J. Gastric absorption of ethyl alcohol in
the rat. Arn. J. Physiol., �: 268-276 (1948).
80.

Kaufman, J. and Raz, S. Narcotic and narcotic antagonist pK a's and
partition coefficients and their significance in clinical practice.
Drug and Alcohol Dep., l_: 103-114 (1976).

81.

Khanna, J., Kalant, H., and Lin, G. Metabolism of ethanol by rat
liver enzymes. Biochern. Pharmacol., �: 2493-2499 (1970).

82. Kissin, B. Interactions of ethyl alcohol and other drugs. In The
Biology of Alcohol ism, Kissin, B. and Begleiter, H., eds., vol .3----:
pp. 109-161. Plenum Press, New York, 1974.
83. Kreek, M. Medical safety and side effects of methadone in tolerant
individuals. J. Arner. Med. Assoc., 223: 665-668 (1973).
84. Kreek, M., Gutjahr, K., Garfield, J., Bowen, D., and Field, F.
Drug Interactions with methadone. Ann. N.Y. Acad. Sci., 281: 350371 (1976).

85. Kuhar, M., Pert, c., and Snyder, S. Regional distribution of opiate
receptor binding in monkey and human brain. Nature, 245: 447-450
(1973).
86. Kutter, H., Teschemacher, H., and Hess, R. Structure-activity cor
relations of morphine-like analgesics based on efficienci�s following
intravenous and intraventricular application. J. Med. Chern., ]l_:
801-805 (1970).

87.

Lieber, C. Alcohol. In Chemical and Bioloqical Aspects of Drug
Dependence, Mule, S. and Bri 11 , H. , eds., pp. 135-162. CRC Press,
Cleveland, 1972.

88. Lieber, C., Teschke, R., and Hasumura, Y. Differences in hepatic
and metabolic changes after acute and chronic alcohol consumption.
Fed. Proc., 34: 2060-2074 (1975).

133
89.

Liebsen, I., Bigelo1<1, G., and Flamer, F. Alcoholism among metha
done patients: a specific treatment method. Amer. J. Psycol.,
130: 483-486 (1973).

90. Linnoila, M., Otterstrom, S., and Anttila, M. Serum chlordiazep
oxide, diazepam and thioridazine concentrations after the simul
taneous ingestion of alcohol or placebo drink. Ann. Clin. Res.,
Hels., §_: 4--6 (1974).
91. Litchfield, J. and Wilcoxon, ·F. A simplified method of evaluating
dose-effect experiments. J. Pharmacol. Exp. Ther., �: 131-144
(1949).
92.

Liu, S. , Chen, K., and �Jang, R. Effects of desiprami ne treatment
on the biliary, fecal, and urinary excretion of methadone in the
rat. J. Pharmacol. Exp. Ther., 198: 308-317 (1976).

93. Liu, S., Ramsey, R., and Fallon, H. Effects of ethanol on hepatic
microsomal drug-metabolizing enzymes in the rat. Biochem. Phar
macol., 24: 369-378 (1975).
94. Liu, S. and Wang,R. Increased analgesia and alterations in distri
bution and metabolism of methadone by desipramine in the rat. J.
Pharmacol. Exp. Ther., �: 94-104 (1975).
95. Loew, G., Berkowitz, D., and Newth, R. Quantum chemical studies
of methadone. J. Med. Chem., 12_: 863-869 (1976).

96. Mccloy, R., Prancan, A., and Nalsono, J. Effects of acetaldehyde
on the systemic, pulmonary, and regional circulations. Cardiovas.
Res.,§_: 216-226 (1974).
97.

McCoy, D., Brown, D., and Forney, R. Toxic interaction of ethanol
and morphine in mice. Toxicol. Appl. Pharmacol., £: 459 (1973),
and personal communication.

98. Maddox, J. and Elliott, B. Problem drinkers among patients on
methadone. Amer. J. Drug Alcohol Abuse,£: 245-254 (1975).
99. Mallach, V., Moosmayer, A., Gottwald, K., and Staak, M. Pharmaco
kinetic studies on absorption and excretion of oxazepam in combina
tion with alcohol. Arzneimittel-Forschung, £= 1840-1845 (1975).
100. Mallov, S. and Baesl, T. Effect of ethanol on rates of elimination
and metabolism of zoxazolamine, hexobarbital and warfarin sodium in
the rat. Biochem. Pharmacol., £!:.: 1667-1678 (1972).
101. Manning, T., Bidansit, J., Cohen, S., and Lukash, L. Evaluation
of the AbuscreenR for methadone. J. For. Sci., 21: 112-120 (1976).

13 4
102.

Marshall, A., Hirst, M., and Blum, K. Analgesic effects of 3 -car
boxysalsolinol alone and in combination with morphine. Experi
entia, .3 3: 754-755 (1977).

103. Masten, L., Peterson, G., Burkhalter, A., and Way, E. Effect of
oral administration of methadone on hepatic microsomal mixed
function oxidase activity in mice. Life Sciences, 14: 16 3 5-1640
(1974).
104. Melville, K., Joron, G., and Douglas, D. Toxic and depressant
effects of alcohol given orally in combination with glutethimide
or secobarbital. Toxicol. Appl. Pharmacol., §..: 3 63- 3 75 (1966).
105.

Mezey, E. Ethanol metabolism and ethanol-drug interactions.
Biochem. Pharmacol., �: 869-875 (1976).

106. Millerschoen, N. and Riggs, D. Homeostatic control of plasma
osmolality in the dog and the effect of ethanol. Amer. J. Physiol.,
217: 43 1-437 (1969).
107. Misra, A. and Mole, S. Stereoselectivity and djfferential meta
bolism in vivo of dextro and -laevo-methadone-1- H. Nature, -241:
281-283-(197 3 ). -108. Misra, A., Mule, S., Bloch, R., and Vadlamoni, N. Physiological
disposition and metabolism of levo-methadone-l-3 H in nontolerant
and tolerant rats. J. Pharmacol:-txp. Ther., �: 287-299 (1973).
109.

Misra, A., Vadlamoni, N., and Mule, S. Chromatographic separation of methadone, some of its metabolites and congeners. J. Chrom.
§]__: 3 79-3 81 (1972).

110. Nakano, J. and Kessinger, J. Cardiovascular effects of ethanol,
its congeners and synthetic bourbon in dogs. Eur. J. Pharmacol.,
11..= 195-201 (1972).
111. National Registry of Human Toxicology, Bureau of Forensic Science,
P.O. Box 999, Richmond, Va. 23 208.
112.

Ngal, M. The hyperalgesic action of barbiturates in mice. Brit.
J. Pharmacol., 24: 170-177 (1965)..

113. Personal communication, New England Nuclear.
114. Nickolls, L. A modified cavett method for the determination of
alcohol in body fluids. Analyst, 85: 840-842 (1960).
115.

Oldendorf, W., Hyman, S., Braun, L., and Oldendorf, S. Blood
brain barrier: penetration of morphine, codeine, heroin, and
methadone after carotid injection. Science, 178: 984-986 (1972).

135
116. Olsen, G. Methadone binding to human plasma proteins.
Pharmacol. Ther., ]:i: 338-343 (1973).

Clin.

117. Patrick, G., Dewey, W., Spaulding, T., and Harris, L. Relation
ship of brain morphine levels to analgesic activity in acutely
treated mice and rats and in pellet-implanted mice. J. Phar
macol. Exp. Ther., 1�: 876-883 (1975).
118. Perkins, M. and Bloch, H. Survey of a methadone maintenance
treatment program. Amer. J. Psychiat., 126: 1384-1396 (1970).
119. Pert, C. and Snyder, S. Properties of opiate receptor binding in
rat brain. Proc. Nat. Acad. Sci., ZQ_: 2243-2247 (1973).
120. Pert, C. and Snyder, S. Opiate receptor: demonstration in. ner
vous tissue. Science, 179: 1011-1014 (1973).
121. Pert, C. and Snyder, S. Opiate receptor binding of agonists and
antagonists affected differentially by sodium. Mal. Pharmacol.,
lQ_: 868-879 (1974-).
122. Pertschuk, L., Sher, J., and Ford, D. A morphological compari
son of the regional distribution of methadone in human and rat
brain as demonstrated by immunofluorescence. Drug and Alcohol
Dep., l: 247-254 (1976).
123. Plapp, B. Rate-1imiting steps in ethanol metabolism and approaches
to changing these rates biochemically. Adv. Exp. Med. Biol.,�:
77-109 (1975).
124. Pohland, A., Boay, H. and Sullivan, H. Synthesis and identifi
cation of metabolites resulting from the biotransformation of
d,1-methadone in man and in the rat. J. Med. Chem., 14: 194-197

\1971).

125. Polacsek, E., Barnes, T., Turner, N., Hall, R. and Wise, G.
Interaction of Alcohol and Other Drugs, 2nd Edition. Addiction
Research Foundation, Toronto, Canada, 1972.
126. Pugliese, A., Martinez, M., Masel1i, A., and Zalich, D. Treat
ment of alcoholic methadone-maintenance patients with disulfiram.
J. of Stud. on Ale.,�: 1584-15-8 (1975).
127. Roach, M. Microsomal ethanol oxidation: activity in vivo and
.i.!l. vitro. Adv. Exp. Med. Biol.,�: 33-55 (1975)-:- -128. Robinson, A. and Williams, f. The distribution of methadone in
man. J. Pharm. Pharmacol., �: 353-358 (1970).
129. Roerig, D., Hasegawa, A., and Wang, R. Effect of phenobarbital
pretreatment on the metabolism and biliary excretion of methadone.
Biochem. Pharmacol., 24: 355-362 (1975).

136
130. Roizin, L. Interaction of methadone and ethanol, cited in
Kissin, B. Interactions of ethyl alcohol and other drugs. In
Biology �Alcoholism, Kissin, B. and Begleiter, H., eds., vol. 3.
p. 127. Plenum Press, New York, 1974.
131. Ross, D. Selective action of alcohols on cerebral calcium levels.
Ann. N.Y. Acad. Sci.,�: 280-294 (1976).
132. Ross, D., Medina, M., and Cardenas, H. Morphine and ethanol:
selective depletion of regional brain calcium. Science, 1:..§.§._:
63-65 (1974).
133. Rubin, E., Gang, H., Misra, P., and Lieber, C. Inhibition of
drug metabolism by acute ethanol intoxication. Amer. J. Med.,
49: 801-806 (1970).
134. Rubin, E. and Lieber, C. Alcohol, alcoholism and drugs. Science,
172: 1097-1102 (1971).
135. Rubin, E., Lieber, C., Alvares, A., Levin, W., and Kuntzman, R.
Interaction of ethanol and microsomal heme protein: its effects
on human drug metabolism. Am. J. Path.,�: 55a (1970).
136. Sadore, M., Syed, M., Schiffrin, M. Preliminary clinical report
on a new analgesic. Ill. Med. J., 117: 425-427 (1960).
137. Sasame, H., Perez-Cruet, J., Di Chiara, G., Tagliamonte, A.,
Tagliamonte, P., and Gessa, G. Evidence that methadone blocks
dopamine receptors in the brain. J. Neurochem., 1l.: 1953-1957
(1972).
138. Schmidt, D. Effect of ethanol intake on phenytoin metabolism in
volunteers. Experementia, 11_: 1313 (1975).
139. Schut, J., File, K., and Wohlmuth, T. Alcohol use by narcotic
addicts in methadone maintenance treatment. Quart. J. Stud. Ale.,
34: 1356-1359 (1973).
140. Scott, N., Winslow, W., and Gorman, D. Epidemiology of alcohol
ism in a methadone maintenance program. In Proce�dings of 5th
National Conference on Methadone Treatment, �2 4-287 .-National
Association for the Prevention of Addiction to Narcotics, New
York, 1973.
141. Shah, N., Donald, A., Bertolatus, J .• and Hixson. B. Tissue
distribution of ]-methadone in nonpregnant, and pregnant female
and male mice: effect of SKF-525A. J. Pharmacol. Exp. Ther.,
199: 103-110 (1976).
142. Shannon, H., Holtzman, S., and Davis, D. Interactions between
narcotic analgesics and benzodiazepine derivatives on behavior
in the mouse. J. Pharmacol. Exp. Ther., �: 389-399 (1976).

137
143. Siegmund, E., Cadmus, R., and Lu, G. A method for evaluating
both non-narcotic and narcotic analgesics. Proc. Soc. Exp.
Biol. Med., �: 729-731 (1957).
144. Smith, J. and Loomis, T. The potentiating effect of alcohol on
thiopental induced sleep. Proc. Soc. Exp. Biol. Med.,?.!}_: 827829 (1951).
145. Smith, R., Rossi, G., and Orzechowski, R. Interactions of chlor
pheniramine ethanol combinations: acute toxicity and antihista
minic activity. Toxicol. Appl. Pharmacol., 28: 240-247 (1974).
146. Smits, S. and Myers, M. Some comparative effects of racemic
methadone and its optical isomers in rodents. Res. Commun. Chem.
Path. and Pharmacol., ?.._: 651-662 (1974).
147. Smits, S. and Takemori, A. Quantitative studies on the antagonism
by naloxone of some narcotic and narcotic antagonist analgesics.
Brit. J, Pharmacol., ]2_: 627-638 (1970).
148. Spaulding, T., Minium, L., Kotake, A., and Takemore, A. The
effect of diazepam on the metabolism of methadone by the liver of
methadone-dependent rats. Drug Metabol. Disp., {: 458-463 (1974).
149. Stanton, H. and Keasling, H. Simultaneous blood alcohol levels
and toothpulp threshold changes following intravenous ethanol
administration to rabbits. Quart. J. Stud. Ale., 18: 205-211
(1957).
150. Steel, G. and Torrie, J. Principles and Procedures of Statistics,
p. 67. McGraw-Hill, New York, New YorK, 1960.
151. Sullivan, H., Rue, S., McMahon, R. The difference in activity
between (+)- and (-)-methadone is intrinsic and not due to a dif
ference in metabolism. J. Pharm. Pharmacol., 27: 728-732
(1975).
152. Sullivan, H., Smits, S., Due, S., Booker, R., and McMah011, R.
Metabolism of ct-methadone: isolation and identification of anal
gesically active metabolites. Life Sciences, 11: 1093-1104
(1972).
153.

Sung, C. and Way, E. The metabolic fate of the optical isomers
of methadone. J. Pharmacol. Exp. Ther., .!:.9.2.: 244-254 (1953).

154.

Sunshine, I., ed. Handbook Qf_Analytical Toxicology, p. 799.
CRC Press, Cleveland, Ohio, 1969.

155. Tabalsoff, B., Anderson, R., and Ritzmann, R. Brain Acetaldehyde
after ethanol administration. Biochem. Pharmacol., 25: 13051309 (1976).

138
156. Takemore, A. Pharmacologic factors which alter the action of
narcotic analgesics and antagonists. Ann. N.Y. Acad. Sci., 281
�:
262-272 (1976),
157. Taylor, R. Ph.D. Thesis, U. of London (1968), cited in Jenner,
P. and Testa, B. Influence of stereochemical factors in drug
metabolism. Drug Metabolism Reviews, I= 148-151 (1974),
158. Thomas, B., Coldwell, B., Solomonraj, G., Zeitz, W., and Trenholm,
H. Effect of ethanol on the fate of pentobarbital in the rat.
Biochem. Pharmacol., .?1__: 2605-2614 (1972).
159. Thurman, R., McKenna, W., and McCafferey, T. Pathways responsible
for the adaptive increase in ethanol utilization following chronic
treatment with ethanol: inhibitor studies with the hemoglobin
free perfused rat liver. Mal. Pharmacol., �: 156-166 (1976).
160. Turnbow, J., Thaete, L., and Peters M. Intestinal absorption
and biliary excretion kinetics of 14c-labeled methadone in the
rat. Arch. Int. Pharmacodyn. Ther., �: 311-322 (1976).
161. Turner, A., Baker, K., Algeri, S., Frigerio, A., and Garattini,
S. Tetrahydropapaveroline: formation in vivo and in vitro in
rat brain. Life Sciences, 1!= 2247-2257"11974). --162. Van Dyke, H. and Ames, R. Alcohol diuresis. Acta. Endocrinol.,
7: 110-121 (1951).
153. Van Schaick, P. Methadone maintenance: problems of evaluation.
School of Criminal Justice, State Univ. of N.Y. at Albany, N.Y.,
(1973).
164. Verebely, K., Volavka, J., Mule, S., and Resnick, R. Methadone
in man: pharmacokinetic and excretion studies in acute and
chronic treatment. Clin. Pharmacol. Ther., 1§_: 180-190 (1975).
165.

Videla, L. and Israel, Y. Factors that modify the metabolism of
ethanol in rat liver and adaptive changes produced by its chronic
administration. Biochem. J., 11:§_: 275-281 (1970).

166. Wagner, K. and Wagner, H. Nil nocere! Hazards of treatment of
accident victims who are under the influence of alcohol (with
barbiturates, morphine and palamidone). Munchen Medizinisch.
Wschr. (Munich), 100: 1923-1925 (1958).

167. \•/allgren, H. and Barry, H. Actions of --Alcohol, vol. 1. pp. 3643. Elsevier, Amsterdam, 1970.
168. Wallgren, H. and Barry, H. Actions of Alcohol, vol. 1, pp. 213224. Elsevier, Amsterdam, 1970.

139
169,

Wallgren, H, and Berry, H, Actions of Alcohol, vol. 2.
714. Elsevier, Amsterdam, 1970,

pp. 621-

170. Walsh, c., Levine, R., and Squires, C. The gastrointestinal
absorption of methadone in the rat. Drug Metabol. Disp. l:
525-529 (1975).
171. Weinstock, M. Acetyl cha 1 ine and cha 1 i nesterase. In Narcotic Drugs:
Biochemical Pharmacology, Clouet, D., ed., pp. 254-261. Plenum
Press, New York, 1971.
172. Whitehouse, L., Paul, C., Coldwell, B., and Thomas, B. Effect of
ethanol on diazepam distribution in rats. Res. Commun. Chem.
Path. Pharmacol ., 11_; 221-242 (1975).

173. Wiberg, G., Coldwell, B., and Trenholm, H. Toxicity of ethanol
barbitu rate mixtures. J. Pharm. Pharmacol., �: 232-236 (1969).

140
APPENDIX I
Determination of Methadone Concentration In Brain
In addition to the 3H and GLC determinations of methadone in
b rain presented in figures 2 &

3

respectively, a combined GLC/ 3 H

assay was employed in order to check the accuracy of brain-methadone
determinations based on the 3H-label.

This procedure was identical

to the GLC assay except prornethazine was used as an internal standard
instead of SKF-525A and the initial solvent extract was split.

A

5 ml aliquot was evaporated and counted to determine the apparent

amount of 3H-methadone. This was corrected for 3H-methadone meta

bolites by using the appropriate factor derived from previous
experiments.

The remaining solvent was back extracted with HzS04

and processed as in the GLC procedure.

In this way, brain levels

based on GLC and on analysis of the 3H-label could be determined in
the same sample.

Since promethazine decomposes to phenothiazine, it

was necessary to purify the stock internal standard solution each day
before use. This was accomplished by TLC separation (154). The

promethazine was extracted from the silica gel with a small amount
of ethanol and then diluted to the appropriate concentration with
water. The GLC results from two brain samples were confirmed by
GC/MS as described in methods. The average ratio of GC-MS/GC levels
was 0.93.

Using this 3H/GLC procedure, the brain concentrations of methadone

· were determined in mice administered either water or 2.5 g/kg ethanol

FIGURE 27
EFFECT OF ETHANOL ADMINISTERED PRIOR TO METHADONE
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to determine methadone by GLC.
* significantly different from control at P <.05
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thirty minutes prior to oral administration of methadone (8. mg/kg).
This dosing protocol was identical to that used in figure 12.

In

this duplicate experiment the GLC brain methadone levels (figure 27)
showed that water-pretreated mice exhibited a rapid absorption of
methadone peaking at thirty minutes while ethanol-pretreated mice
showed a delayed absorption with brain methadone levels initially
lower and finally greater than control.

These results confirm the
time course of brain methadone levels based on 3H-analysis found in
the previous set of animals (figure 12).

In addition, the 3H-methadone

concentrations from the combined 3H/GLC procedure indicated exactly

the same trend.

It 1�as observed, however, that the absolute magnitude

of the 3H-methadone concentrations tended to be lower than the concentrations calculated on the basis of the GLC assay.
To investigate the magnitude and mechanism of this difference, in
addition to comparison of brain methadone levels from the two assays,
the specific activity of the methadone recovered from the brains was
also determined.

The calculation of this final specific activity was

accomplished by determination of the number of nanograms of methadone in
identical aliquots of the final extract by both GLC and scintillation
counting. In both cases, the samples were compared to known aliquots of
3H-methadone from the injection solution on the basis of absolute metha
done peak height or DPM. . The remaining extract was analyzed by TLC to
obtain the correction factor for total DPM to methadone DPM.

Since the

GLC detennination of absolute nanograms of methadone relies on the abso
lute peak height of methadone and it was found that a small amount of
promethaz1ne decomposes to phenothiazine during the process of

extraction, and further, that phenothiazine elutes very close to
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methadone, the internal standard for this and all subsequent GLC
analyses was changed to SKF-525A.
Although this made the determination of specific activity more
accurate, it was found that SKF-525A is extracted approximately half
as efficiently from mouse brains homogenates as it is from human
brain homogenates although methadone is extracted equally well from
both.

The same type of problem has been noted by at least one other

worker (23) who found the extraction of methadone to be equally

efficient in all tissues studied but also noted that SKF-525A

extracted with a different efficiency in each type of tissue studied
(brain, liver, lung, spleen, kidney).

Due to this difference in

the extraction of SKF-525A, at least one standard prepared in mouse
brain homogenates was.coextracted with each group of samples and
human-brain standards.

The standard curve established with human

brain standards was corrected for the difference in extraction of the
internal standard by the mouse-brain standards. This difference was
very reproduceable from day to day.

The average ratio of peak height

ratios (methadone/SKF-525A) between mouse and human brain standards
was 2.06 + .07 based on five standards over a three week peri6d.
Table 19 presents the alterations in specific activity as well

as the 3H/GLC results from the analysis of brains from mice pretreated
with ethanol or water thirty minutes prior to the oral administration
of methadone (8 mg/kg). These results confirm the reality of the
difference between 3H and GLC methadone concentrations and show that
the observed differences in 3H and GLC concentrations are caused by a
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TABLE 19
TIME COURSE OF ALTERATIONS IN SPECIFIC ACTIVITY
Minutes post
methadone
(Pretreatment)
30, (water)
30, (ethanol)
90, (water)

90, (ethanol)

There

v1ere

Specific activity

o.ao

3H/GLC

.os

0.78 + .09

0.83 + .08

0.81 + .05

0.68 + .10

0.71 + .06

0.74 � .06

0.75 + .07

+

three samples /dose with two mouse brains/sample. Mice

were pretreated with either water or ethanol(2.5g/kg, p.a.) 30 minutes
prior to recieving 3H-l-methadone diluted with unlabelled &,l methadone
( 8 mg/kg, p.o.).
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decrease in the specific activity of methadone and were not
due to improper application or calibration of either analytical
method.

In addition, these results demonstrate that the magni.tude

of the decrease-thirty minutes post administration was almost the
same as at ninety minutes and was not altered by pretreatment with
ethanol.
Since all the radiolabled methadone was l which had been
diluted with unlabled _c!,_J_-methadone, one of the reasons for the
decreased specific activity could be stereoselective·metabolism
of methadone or a more rapid metabolism of _l-methadone than!!
methadone.

Although Sung and Way (153) found that each enantiomer

of methadone had the same brain half-life, other workers (15, 107,
157) showed that the metabolism of _c!-methadone is faster than l,
which would, if anYthing, tend to increase the specific activity.
These studies were all done with each enantiomer separately and,
as shown by Taylor (157), when the racemic mixture was studied, the meta
bolism of 1-methadone was favored over that of d-methadone.

Beckett

(15) suggested that this could be explained by _l-methadone possessing
a higher affinity for the metabolizing enzyme but a slower matabolic
rate than _c!-methadone.

If this is true, l-methadone would inhibit the

metabolism of _c!-methadone and this would tend to decrease the specific
activity of 3H-_J_-methadone diluted with _c!,_l-methadone.
Table 20 shows that when 3H-_J_-methadone diluted with _c!,l
methadone was administered subcutaneously rather than orally, there
was no alteration in the specific activity, and there was a very
close agreement between 3H and GLC methadone concentrations. This
tends to discount the importance of stereoselective metabolism as
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TABLE 20

CHANGES IN SPECIFIC ACTIVITY OF 3 H-METHAD0NE

.9.,l �lethadone

Ratio of final/initial
ecific activit

3
H brain level
GLC brain 1 evel

s.c.

1.02

.05

o. 97

+

p.o.

0. 71 ±. .08

0.73

.05

+

.05

s.c.

1.03

+

.07

1.06

+

. 03

p. 0.

0.78

+

.05

0.70

+

.07

+

Methadone

Specific activity and brain methadone 1 eve1 s v1ere determined
90 minutes after methadone was administered ( 8 mg/kg p.o. or
2 mg/ kg

S. C. ) •
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the cause of the decreased specific activity seen after oral
administration. In addition, as also shown in table 26, when
3tt-l-methadone was diluted with unlabeled l-methadone the specific
activity still decreased after oral but not after subcutaneous
administration, further indicating a mechanism other than stereoselective metabolism.

The data that indicate no alteration in
the specific activity of 3tt-l- methadone diluted with unlabeled

1,1-methadone are in agreement with the results of Alvares and

Kappas (3) and Sullivan et�. who found no difference in the i.!!.
vitro rate of metabolism of methadone isomers in rat liver.microsomes
(l 51).

It is possible that there is an irreversable stereoselective
binding of methadone to the "narcotic receptor" or other brain constituents which favors l-methadone and thus decreases the specific
activity of recovered methadone. The decreased specific activity after
oral administration of 3H-l-methadone diluted with l- methadone and
the lack ·of alteration of specific activity of 3tt-l-methadone diluted

with 1,l-methadone after subcutaneous administration discounts stereo
selective binding as a reason for decrease in specific activity.
. The most likely explanation for the observed alterations in specific

activity is exchange of the 3tt-labe1 with water. This exchange could
conceivably occur during the extraction of the samples but since the
specific activity of the standards which were processed in parallel
with the samples was unaltered, this does not seem likely.

To deter

mine if the exchange was taking place during storage or homogenization
of the brains, aliquots of an injection solution were injected fnto
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several sites of four blank mouse brains such that each brain received
10 µl of solution.

The brains were then frozen and two were analyzed

after two days of storage.
days of storage.

the remaining two were analyzed after ten

In both cases the specific activity of methadone

was found to be unaltered.

In addition, since all brain samples

were stored, homog·enized and extracted in the same manner but alter
ations of specific activity were only observed in mice dosed orally,
these procedures cannot be the source of the exchange.

In view of

the alteration in specffic activity following oral but not subcutaneous
administration, the exchange with water is probably occuring in the
gastrointestinal tract.

Evaluation of the exchange of 3H-methadone 1vas monitored by

measuring the amount of 3H which was extracted by EDC/isopropanol before
and after incubation in �,ater.

Incubation of 3H-methactone in water at

35° c resulted in a 5% decrease in extractable radioactivity after 30
minutes but no further decrease in the next 24 hours.

Incubation at

°

pH 7.4 and 35 c did not result in any measurable decline in 24 hours.
Information from the manufacturer of the 3H-methadone used (113)

indicated that approximately 5% of the 3 H-lable is not in the l posi

tion. Since the 3H-methadone is produced by reaction of 1-4-dimethyl
amiAe-2,2-diphenylvaleronitrile with ethyl magnesium bro�ide (2-3H),

it would seem likely that this 5% is in the 2 position next to the
carbonyl group. This. position would be ve_ry labile and in fact exchange
at this position of methadone has been observed (66).

This type of

exchange .could explain the observed� vitro decrease in extractable
3H. However, in addition to instability in vitro, there .must be an
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additional exchange iD.. vivo since the specific activity of
recovered methadone is decreased by approximately 30%.

Since the

decrease of specific activity is not affected by pretreatment with
ethanol (table 14) which causes a delay in the loss of methadone
from the stomach (table 8) this additional exchange may occur in the
small intestine.
The data presented here suggest that following oral administration

of 3H-methadone there is an exchange of the 3H-label which results in
an approximate 30% decrease in specific activity. The same decrease

in specific activity is not observed following subcutaneous administra

tion. The decrease in specific activity is not affected by pretreat
ment with ethanol and furthermore, the decrease at 30 minutes post

methadone is almost the same as at 90 minutes.

In experiments where

both 3H and GLC methods were used to determine methadone concentration
in the brain after oral administration it was found that each assay
showed the same relative magnitude between ethanol and water pretreated
animals and a similar time course of brain methadone levels.

However,

the absolute magnitude of the 3H-levels was lower due to the change

in specific activity. Although it would have been valid to correct
the 3H-methadone concentrations for alterations in specific �ctivity
and report these results as ng of methadone/g of brain, this was not
done.

Results based on 3H-ana1ysis after oral administration of metha

done are reported as OPM/g. The results after subcutaneous administra
tion are reported as ng methadone/g since no alteration of specific
activity occured with this route of administration.
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APPENDIX II
The results of administration of ethanol 30 minutes prior to the
subcutaneous administration of morphine, propoxyphene or meperidine
are presented in figures 28, 29 and 30 respectively. This dosing pro
tocol is identical to· that used for methadone in figure 8.

Under

these conditions, the brain concentration of methadone was decreased
relative to control concentrations.
If the factors which produced this decline in brain concentrations
of methadone also decreased brain concentrations of these other narcotics to a similar degree, then the antinociceptive properties of these
agents would also seem to be increased by ethanol pretreatment.
I

If the

brain concentration of these agents was decreased to the same extent as
methadone, these other·,narcotics would seem to be potentiated to a
lesser degree than methadone in that ethanol increased methadone anti
nociception to such an extent that even in the face of decreased brain
concentrations of methadone, the ethanol and methadone antinociceptive
response was greater than control.

Ethanol and these other narcotics

generally produced antinociceptive responses equal to control responses.
On the other hand, if ethanol pretreatment does not alter the
brain concentration of these agents, then it would seem that ethanol is
unable to increase the antinociceptive properties of these narcotics.
Further investigation of the combined effects of ethanol and these
narcotics is needed to differentiate between these possibilities.

FIGURE 28
THE EFFECT OF ETHANOL ON THE TIME COURSE OF THE
TAIL-FLICK ACTIVITY OF MORPHINE
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was tested at the indicated times. The SEM shown are represen
tative of the SEM at the other time points.
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FIGURE 29

THE EFFECT OF ETHANOL ON THE TIME COURSE OF THE
TAIL-FLICK ACTIVITY OF PROPOXYPHENE
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Minutes Post Propoxyphene (30 mg)<g s.c.)

Ethanol (2.5 g/kg, p.a.) or water was administered 30 minutes
prior to propoxyphene. There were six mice/group. Mice tested
at 60 minutes were retested at 120 minutes. Mice tested at 90
minutes were retested at 135 minutes. The SEM shown are represen
tative of the SEM in the other groups.
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FIGURE 30

THE EFFECT OF ETHANOL ON THE TIME COURSE OF THE
TAIL-FLICK ACTIVITY OF MEPERIDINE
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Minutes Post Meperidine (s.c.)

Ethano 1 ( 2. 5 g/ kg, p.o.) or water was administered 30 minutes
prior to meperidine. There were six mice/dose and each mouse
was tested at the indicated times.

